hg_218572.1

Basic information about the TSS

---

TSS ID: hg_218572.1 Species: human Chr: chr5		Start: 34687581 End: 34687582 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000506376.1 AY354204 Distance: -23 GeneID: 26064 HGNC/MGI_ID: HGNC:14873 UniProt_ID: Q9P0K7

Gene_name: retinoic acid induced 14 Gene_symbol: RAI14 Gene_synonyms: DKFZp564G013 KIAA1334 NORPEG RAI13 Gene_source: HGNC:14873

TATA-Box annotation

---

Distance to TSS:	23
Nearest PromoterID:	NM_001145523
Entrez ID:	26064
Nearest Unigene:	Hs.431400
Nearest Refseq:	NM_015577
Nearest Ensembl:	ENSG00000039560
Gene Name:	retinoic acid induced 14
Gene Alias:	NORPEG|RAI13
Gene Description:	retinoic acid induced 14
Gene Type:	protein-coding
CpG%:	0.005
GC%:	0.402985
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):	-99(ATCCATAAAAGA,-,0.00),16(TTTTTTAAAAGG,-,0.00)

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RAI14 p2@RAI14 p3@RAI14 p4@RAI14 p5@RAI14 p6@RAI14 p7@RAI14 p8@RAI14
Sample		p1@RAI14	p2@RAI14	p3@RAI14	p4@RAI14	p5@RAI14	p6@RAI14	p7@RAI14	p8@RAI14
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	10.52	3.12	0.58	2.53	1.56	0.58	0.00	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	9.71	3.64	2.23	1.01	1.82	1.01	0.20	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	14.27	3.47	0.39	1.35	1.16	0.19	0.00	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	9.77	2.49	0.83	1.25	1.66	0.42	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	10.80	5.62	1.80	0.67	0.67	1.35	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	10.27	3.10	1.16	1.74	1.36	0.97	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	13.51	3.92	0.87	1.74	2.83	0.65	0.00	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	12.35	2.91	1.70	2.91	1.94	0.73	0.00	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	8.12	3.42	1.71	1.28	0.64	1.07	0.21	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	6.96	6.38	2.32	1.74	2.90	2.32	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	6.06	1.21	0.40	1.21	0.40	0.40	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	5.69	1.63	2.44	1.22	0.41	0.81	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	21.60	10.64	4.19	1.61	1.45	1.29	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	23.60	10.22	2.41	1.05	1.20	0.15	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	15.59	8.12	3.29	1.98	1.32	0.00	0.22	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	17.86	7.04	2.51	2.77	1.01	0.75	0.25	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	15.29	5.68	2.62	1.75	0.22	0.66	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	18.56	6.75	1.27	1.27	0.00	0.42	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	14.40	6.40	1.07	1.07	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	20.31	6.62	1.65	1.05	1.81	0.45	0.45	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	20.98	7.62	3.07	0.80	1.34	0.67	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	18.64	8.29	4.66	2.24	1.38	0.17	0.00	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	18.23	9.31	2.71	1.94	0.78	0.00	0.39	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	19.17	7.04	2.67	0.97	1.70	0.73	0.00	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	20.38	4.64	3.10	1.03	0.52	0.77	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	20.26	7.60	2.22	0.63	0.63	0.95	0.00	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	19.78	10.99	1.65	0.55	1.10	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	26.17	14.62	4.48	1.89	1.41	0.00	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	18.74	6.46	4.04	1.13	0.81	0.16	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	21.35	9.23	2.53	1.63	0.54	0.36	0.18	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	20.52	10.68	2.30	0.84	1.47	0.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	16.22	7.62	1.56	0.78	1.17	0.78	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	20.26	7.81	2.95	0.84	1.06	0.63	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	20.95	9.07	3.79	1.15	0.66	0.33	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	22.06	8.60	2.62	1.31	0.75	0.19	0.00	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	19.16	9.96	2.87	1.72	1.53	1.15	0.00	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	24.12	7.36	4.50	1.02	2.04	0.41	0.20	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	24.18	7.25	3.43	0.81	1.41	0.40	0.40	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	22.15	8.64	5.13	1.62	0.27	0.54	0.27	1.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	21.85	7.20	2.88	2.16	0.72	0.96	0.48	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	22.82	9.41	2.12	0.71	0.71	0.24	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	21.81	6.88	4.10	0.88	1.76	0.88	0.44	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	18.56	7.17	3.59	2.11	1.05	0.00	0.21	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	20.98	8.74	3.67	2.10	0.17	0.17	0.17	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	20.88	7.23	5.02	1.61	0.60	0.20	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	16.29	7.44	2.79	0.93	0.93	0.47	0.00	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	20.63	7.68	3.12	0.72	1.92	0.96	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	14.31	6.56	2.98	1.19	0.30	0.00	0.30	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	16.52	5.98	4.79	1.20	1.44	0.72	0.96	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	16.18	7.48	2.43	1.01	0.81	0.61	0.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	18.04	7.17	3.48	1.64	0.61	0.20	0.61	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	21.13	5.56	3.56	1.11	0.67	0.44	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	13.99	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	21.65	7.10	3.90	1.77	0.71	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	18.89	4.64	3.98	2.32	0.99	0.33	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	43.62	17.62	7.55	1.68	0.00	1.68	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	25.26	7.35	4.59	0.00	0.00	1.38	0.00	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	17.50	8.75	5.51	1.30	1.30	0.00	0.65	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	19.91	4.18	6.42	1.28	1.61	1.61	0.64	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	34.26	8.17	3.77	0.94	0.63	0.63	0.31	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	20.45	3.53	7.05	0.71	0.00	0.71	0.71	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	17.38	8.97	5.05	0.56	1.12	0.00	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	31.05	5.57	6.37	3.18	1.59	0.80	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	18.35	5.44	5.10	1.02	1.02	0.00	0.00	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	13.32	6.82	3.57	0.65	0.65	0.00	0.32	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	14.55	7.10	3.19	0.71	0.71	0.00	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	96.98	32.33	16.16	16.16	0.00	0.00	0.00	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	55.28	23.69	15.79	7.90	0.00	0.00	7.90	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	31.20	9.26	7.31	0.49	0.49	0.49	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	22.31	10.91	3.47	1.49	2.48	0.50	0.50	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	24.86	7.97	6.10	1.41	1.88	0.00	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	27.49	8.28	3.31	0.66	0.99	0.33	1.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	19.49	10.83	2.47	0.93	1.55	0.62	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	23.54	8.87	1.53	1.83	1.83	0.61	0.61	0.00
Adipocyte - breast, donor1	11376-118A8	10.93	6.02	2.69	2.06	1.43	1.43	0.32	0.48
Adipocyte - breast, donor2	11327-117E4	10.75	6.26	1.28	1.12	1.28	0.64	0.00	0.16
Adipocyte - omental, donor1	11473-119C6	10.69	6.49	1.78	1.78	1.40	0.76	0.13	0.13
Adipocyte - omental, donor2	11474-119C7	12.71	12.71	2.24	2.24	0.00	0.75	0.75	0.75
Adipocyte - omental, donor3	11475-119C8	5.02	10.05	0.33	1.00	0.33	1.67	0.00	0.33
Adipocyte - perirenal, donor1	11476-119C9	8.93	8.29	3.83	1.28	1.28	1.91	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	6.60	9.90	0.00	0.00	1.10	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	21.68	8.13	3.61	3.61	2.26	1.35	0.45	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	1.91	0.52	0.00	0.00	0.70	0.17	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	14.08	5.67	1.17	0.59	1.76	0.59	0.00	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	17.76	9.78	2.06	1.80	1.54	1.03	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	2.79	3.90	0.00	1.12	1.39	0.56	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	7.05	1.76	0.59	0.00	0.59	1.18	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	2.17	0.72	0.32	0.56	0.32	0.24	0.00	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	4.20	1.94	0.65	0.32	0.65	0.65	0.00	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	1.60	0.53	0.00	0.53	0.53	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	1.11	0.00	0.00	0.00	0.00	1.11	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	2.08	0.42	0.42	0.42	0.42	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	3.27	1.00	0.25	0.25	0.50	0.75	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	2.62	0.65	0.00	0.65	0.00	0.33	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	1.52	0.61	0.30	0.61	0.61	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	12.60	6.85	1.99	1.33	2.65	1.33	0.00	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	3.94	1.43	0.72	1.08	0.36	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	7.19	5.99	0.00	3.59	0.00	0.00	0.00	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	2.70	2.16	1.26	0.90	0.36	1.08	0.00	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	1.67	0.00	0.00	3.35	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	2.88	2.47	0.41	0.62	0.21	0.41	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	12.93	5.03	2.40	1.03	0.92	0.23	0.11	0.23
Anulus Pulposus Cell, donor2	11463-119B5	10.78	8.08	2.69	1.22	0.98	0.24	0.73	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	19.77	10.33	5.84	0.90	2.70	1.35	0.90	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	19.54	13.02	5.21	1.74	1.74	2.60	0.43	1.74
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	8.56	6.42	6.42	2.14	2.14	0.00	2.14	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	20.92	10.16	5.38	1.49	1.79	1.49	0.60	1.20
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	20.23	13.91	6.32	3.79	0.00	0.00	3.79	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	7.92	9.24	3.96	0.66	0.66	1.32	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	21.44	7.47	9.75	2.27	1.62	0.97	0.65	1.30
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	22.82	11.65	4.37	2.43	1.46	1.94	0.97	1.46
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	13.66	4.75	1.78	1.78	0.59	0.59	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	22.60	16.57	4.52	1.13	2.26	0.00	1.13	3.01
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	21.04	10.89	4.35	0.73	3.63	1.45	1.45	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	15.05	3.76	3.76	0.00	1.25	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	24.05	10.21	5.77	1.81	0.66	1.81	0.16	0.99
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	21.84	9.55	4.09	0.00	4.09	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	16.74	8.75	3.77	2.71	1.21	0.60	0.90	0.90
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	18.75	14.47	6.43	1.07	2.14	1.61	0.00	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	22.29	13.60	5.67	1.51	2.27	0.94	1.32	0.94
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	15.77	6.95	4.81	1.60	0.53	0.80	0.53	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	18.53	11.71	5.85	0.98	1.95	0.00	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	23.88	13.27	5.47	1.16	1.82	1.33	0.33	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	14.41	4.80	4.80	1.20	0.00	1.20	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	28.32	7.08	3.54	0.00	0.00	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	19.38	14.58	5.83	1.37	2.74	1.20	0.34	1.03
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	0.00	4.19	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	14.56	9.22	4.85	0.49	0.97	1.46	2.43	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	24.66	8.35	7.59	1.14	4.55	1.14	0.76	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	4.85	6.06	0.00	1.21	1.21	0.00	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	15.96	9.69	6.27	0.00	0.57	0.57	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	20.31	9.19	5.56	0.64	2.35	1.28	0.64	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	9.55	6.19	3.36	0.52	1.29	1.03	0.52	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	13.61	14.08	3.28	0.94	1.88	0.00	0.00	1.41
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	23.47	12.22	7.07	2.25	1.93	0.64	0.64	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	11.42	6.42	6.42	0.71	0.71	0.00	0.71	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	13.45	9.94	4.09	0.58	1.17	0.58	0.00	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	19.27	8.73	5.42	1.51	0.90	0.30	1.81	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	13.07	5.94	0.00	1.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	24.41	11.70	2.54	3.56	1.53	1.02	1.02	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	21.65	12.23	6.62	1.02	1.53	1.27	0.76	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	7.62	4.45	2.54	1.27	0.64	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	11.65	9.93	5.18	2.16	1.73	0.86	2.59	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	17.99	10.80	5.08	1.48	1.91	1.27	0.85	1.06
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	11.60	3.77	1.16	1.45	0.87	0.58	0.58	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	20.78	17.01	4.72	0.94	1.89	0.94	0.94	2.83
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	20.68	11.19	7.29	1.36	0.85	1.02	1.19	0.68
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	13.90	2.32	6.95	0.00	2.32	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	14.79	8.45	10.56	2.11	4.23	4.23	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	27.23	13.51	9.86	1.07	3.43	1.29	1.29	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	15.64	3.61	1.20	2.41	0.00	1.20	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	16.04	12.39	2.19	1.46	0.73	1.46	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	24.60	18.85	7.13	1.15	2.07	1.38	0.92	1.38
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	20.40	2.55	5.10	0.00	2.55	0.00	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	19.07	9.92	3.81	1.27	2.29	0.76	1.02	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	20.23	17.75	6.61	1.03	1.86	1.24	0.41	0.83
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	20.20	10.71	4.59	0.92	1.22	0.61	1.53	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	18.16	12.91	4.30	1.43	2.39	0.96	0.00	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	17.30	10.42	7.76	1.11	2.44	0.89	0.67	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	6.10	4.58	1.53	1.53	0.00	0.00	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	17.72	8.86	4.43	1.66	3.88	2.22	0.55	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	19.86	8.74	4.50	1.59	2.12	1.32	0.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	11.99	5.45	2.18	1.82	1.09	0.36	0.73	0.73
Astrocyte - cerebellum, donor1	11500-119F6	6.63	2.58	3.44	1.23	0.86	0.61	0.00	0.12
Astrocyte - cerebellum, donor2	11580-120F5	6.68	3.59	2.40	1.54	0.51	1.03	0.00	0.34
Astrocyte - cerebellum, donor3	11661-122F5	4.40	1.47	1.26	0.21	0.42	0.00	0.00	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	40.09	17.43	3.14	2.79	2.44	1.05	0.35	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	36.24	14.24	2.75	3.72	1.78	0.65	0.00	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	41.32	22.67	2.98	4.62	4.03	2.24	0.15	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	0.00	0.00	0.13	0.00	0.00	0.00	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Basophils, donor1	12241-129G9	0.00	0.00	0.26	0.26	0.00	0.00	0.00	0.00
Basophils, donor2	12242-129H1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Basophils, donor3	12243-129H2	0.59	0.00	0.00	0.15	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	1.08	0.43	0.65	0.65	0.22	0.22	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	2.74	3.20	0.00	0.00	0.46	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	5.02	4.39	0.00	0.00	0.00	1.88	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	3.95	3.54	0.83	1.25	0.62	1.25	0.00	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	2.99	2.30	0.69	0.92	0.23	0.23	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	3.42	4.68	0.00	1.44	0.90	1.62	0.18	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	0.00	0.00	0.32	0.00	0.00	0.00	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	0.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	0.00	0.00	0.19	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	0.00	0.28	0.28	0.00	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	0.00	0.00	0.38	0.00	0.00	0.38	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	0.99	0.33	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	3.18	1.59	4.19	0.29	0.00	0.14	0.43	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	1.21	0.30	1.51	0.00	0.00	0.30	0.30	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	3.08	0.95	3.55	0.00	0.47	0.24	0.47	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	0.50	0.50	0.33	0.00	0.00	0.00	0.17	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	0.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	0.74	0.00	0.74	0.25	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	0.20	0.00	0.20	0.00	0.00	0.00	0.20	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	0.00	0.00	0.18	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	0.00	0.22	0.44	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	0.47	0.00	0.70	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	0.00	0.00	0.53	0.00	0.53	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	0.89	0.74	1.93	0.30	0.00	0.15	0.30	0.59
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	2.20	0.60	1.60	0.40	0.00	0.00	0.20	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	1.46	0.83	2.08	0.00	0.00	0.21	0.00	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	0.69	0.46	1.60	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	0.23	0.23	0.45	0.00	0.23	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	0.00	0.00	0.44	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	0.81	0.00	0.27	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	0.00	0.00	0.17	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	0.84	0.42	0.84	0.00	0.42	0.00	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	0.18	0.00	0.18	0.00	0.18	0.00	0.00	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	0.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	0.00	0.00	0.44	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	0.35	0.17	0.52	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	0.00	0.00	0.37	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	0.22	0.22	0.22	0.00	0.00	0.00	0.00	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	0.41	0.82	0.00	0.00	0.00	0.41	0.82	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	0.00	0.23	0.23	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	0.46	0.23	0.46	0.00	0.00	0.00	0.00	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	0.00	0.00	0.00	0.00	0.00	0.23	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	0.54	0.00	0.54	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	0.70	0.00	0.70	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	0.00	0.00	1.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	0.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	0.23	0.23	0.23	0.23	0.00	0.00	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	0.00	0.00	0.26	0.26	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	0.00	0.00	0.00	0.00	0.00	0.17	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	0.00	0.27	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	0.00	0.00	0.54	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	0.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	0.00	0.00	0.44	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	0.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	0.25	0.00	0.25	0.00	0.00	0.00	0.00	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	0.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	5.28	0.46	1.61	0.92	0.46	0.46	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	5.03	1.68	0.48	0.24	0.00	0.24	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	3.01	0.27	1.09	0.55	0.27	0.00	0.27	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	5.70	0.00	0.60	1.20	0.00	0.00	0.00	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	4.56	1.92	0.96	0.72	0.00	0.00	0.24	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	4.78	1.59	0.45	0.45	0.23	0.45	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	3.69	0.87	0.43	0.43	0.00	0.22	0.22	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	3.16	0.79	0.79	0.00	0.00	0.00	0.00	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	4.46	0.47	0.23	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	4.53	0.30	1.21	0.30	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	3.49	1.16	0.58	0.00	0.00	0.29	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	3.20	0.27	1.87	0.27	0.00	0.00	0.00	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	3.94	0.88	0.88	0.00	0.00	0.00	0.00	1.31
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	2.73	0.91	0.46	0.46	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	2.24	1.49	0.75	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	5.04	1.80	0.00	0.72	0.36	0.00	0.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	5.47	0.29	0.86	0.86	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	3.54	0.24	0.47	0.71	0.24	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	7.29	1.27	1.90	0.63	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	5.84	0.92	1.85	0.62	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	4.81	0.64	1.60	0.64	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	3.44	0.38	0.76	1.15	0.00	0.00	0.00	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	3.94	0.79	1.58	0.79	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	4.54	0.00	2.27	0.76	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	3.21	0.80	0.80	0.80	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	4.90	0.70	0.00	0.00	0.00	0.00	0.00	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	2.00	0.00	1.00	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	10.97	9.14	1.83	0.00	0.00	0.00	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	7.91	4.45	6.42	0.99	0.49	0.99	0.49	0.99
Cardiac Myocyte, donor3	11686-122I3	28.73	19.36	9.37	2.63	2.42	0.53	1.05	0.84
Chondrocyte - de diff, donor1	11261-116G1	14.21	9.36	2.08	0.00	1.04	1.04	0.00	0.69
Chondrocyte - de diff, donor2	11338-117F6	8.17	4.62	2.84	1.42	0.71	0.71	0.36	0.00
Chondrocyte - de diff, donor3	11410-118E6	15.93	7.62	1.93	1.14	1.14	1.14	0.00	0.23
Chondrocyte - re diff, donor2	11339-117F7	17.91	11.64	2.69	0.00	1.79	2.69	0.90	1.79
Chondrocyte - re diff, donor3	11411-118E7	8.90	7.28	2.83	1.62	1.21	0.81	0.40	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	43.26	9.41	9.41	2.18	3.33	2.30	1.15	1.49
Ciliary Epithelial Cells, donor2	11323-117D9	41.90	12.18	11.12	1.50	3.85	1.28	1.07	1.50
Ciliary Epithelial Cells, donor3	11399-118D4	56.11	16.99	13.27	3.54	4.25	1.24	0.88	1.24
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	11.46	4.49	2.75	0.92	0.64	0.92	0.37	0.73
Corneal Epithelial Cells, donor1	11526-119I5	0.66	0.22	0.22	0.22	0.22	0.22	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	2.28	0.00	0.00	1.14	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	1.53	2.05	0.26	0.00	1.53	0.77	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	1.32	0.17	0.33	0.17	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	1.58	0.00	0.63	0.63	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	1.84	0.65	0.76	0.11	0.00	0.00	0.00	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	8.51	4.00	21.68	1.00	0.00	0.17	8.00	3.67
Endothelial Cells - Aortic, donor1	11263-116G3	5.28	5.28	11.74	0.00	0.00	0.00	7.04	2.93
Endothelial Cells - Aortic, donor2	11340-117F8	10.75	8.77	14.14	1.41	0.85	0.00	8.48	2.83
Endothelial Cells - Aortic, donor3	11412-118E8	5.90	3.93	12.58	0.39	1.18	0.00	11.01	2.36
Endothelial Cells - Artery, donor1	11264-116G4	3.49	3.78	14.25	1.16	0.29	0.00	4.65	1.75
Endothelial Cells - Artery, donor2	11341-117F9	14.82	8.71	21.88	0.47	0.47	0.00	10.12	3.53
Endothelial Cells - Artery, donor3	11413-118E9	8.06	4.03	14.02	0.53	1.05	0.18	4.03	2.28
Endothelial Cells - Lymphatic, donor1	11236-116D3	17.51	7.98	30.81	1.77	0.89	0.66	12.19	4.43
Endothelial Cells - Lymphatic, donor2	11317-117D3	21.60	10.35	46.86	0.30	1.22	0.00	14.91	3.65
Endothelial Cells - Lymphatic, donor3	11393-118C7	23.12	10.99	64.84	2.82	1.97	0.85	15.79	9.58
Endothelial Cells - Microvascular, donor1	11265-116G5	7.43	5.65	24.36	1.19	0.00	0.00	8.32	6.54
Endothelial Cells - Microvascular, donor2	11342-117G1	10.93	5.73	26.55	0.52	0.00	1.04	9.89	2.60
Endothelial Cells - Microvascular, donor3	11414-118F1	3.69	1.84	9.64	0.71	0.28	0.00	7.09	2.13
Endothelial Cells - Thoracic, donor1	11266-116G6	17.61	9.60	50.42	0.40	1.20	0.00	9.60	7.20
Endothelial Cells - Thoracic, donor2	11343-117G2	6.81	3.67	15.72	0.00	0.52	0.00	5.77	2.10
Endothelial Cells - Umbilical vein, donor1	11243-116E1	21.12	7.83	50.32	2.61	1.62	0.25	14.91	9.57
Endothelial Cells - Umbilical vein, donor2	11324-117E1	19.77	9.56	26.29	1.74	1.74	0.65	15.86	6.95
Endothelial Cells - Umbilical vein, donor3	11400-118D5	24.18	9.89	36.27	1.59	2.69	0.37	14.66	7.94
Endothelial Cells - Vein, donor1	11267-116G7	9.10	7.96	23.89	0.00	0.00	0.00	22.75	1.14
Endothelial Cells - Vein, donor2	11344-117G3	10.48	6.99	19.56	0.70	1.40	0.00	12.57	3.49
Endothelial Cells - Vein, donor3	11416-118F3	17.27	5.81	29.05	1.10	1.26	0.63	20.10	3.61
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	1.47	0.49	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	2.08	0.00	2.08	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	16.27	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	17.65	7.80	4.11	1.64	0.00	0.41	0.41	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	13.80	9.31	2.41	1.97	1.42	0.33	0.22	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	9.53	4.55	1.95	1.41	0.76	0.33	0.22	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	24.86	12.37	6.79	2.43	3.64	1.46	0.61	1.21
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	63.05	36.71	13.92	4.64	1.36	1.09	2.73	1.09
Fibroblast - Aortic Adventitial, donor2	11326-117E3	20.14	13.39	3.80	1.79	2.21	1.05	0.63	0.74
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	14.76	12.38	6.32	0.53	0.26	0.79	0.26	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	15.61	7.97	3.65	2.33	0.66	1.00	0.33	0.33
Fibroblast - Cardiac, donor1	11268-116G8	21.77	22.68	6.35	3.18	0.91	0.91	0.00	0.45
Fibroblast - Cardiac, donor2	11345-117G4	31.83	9.10	9.85	3.03	3.79	0.00	1.52	2.27
Fibroblast - Cardiac, donor3	11417-118F4	11.67	8.36	3.15	1.26	1.73	0.95	0.47	0.16
Fibroblast - Cardiac, donor4	11452-119A3	23.34	16.37	6.06	1.52	0.91	0.30	1.52	0.30
Fibroblast - Cardiac, donor5	11456-119A7	15.61	11.55	10.03	2.16	1.27	1.02	2.03	1.27
Fibroblast - Cardiac, donor6	11460-119B2	21.83	11.37	11.98	1.06	1.52	0.91	1.67	2.58
Fibroblast - Choroid Plexus, donor1	11492-119E7	6.30	1.61	3.22	0.54	0.27	0.27	0.27	0.67
Fibroblast - Choroid Plexus, donor2	11572-120E6	9.49	3.45	4.31	0.00	0.86	0.00	0.00	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	32.23	14.65	14.65	1.46	1.46	1.46	0.00	2.93
Fibroblast - Conjunctival, donor1	11531-120A1	8.07	4.38	0.92	0.46	0.69	0.69	0.00	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	12.38	3.56	1.53	1.87	1.02	1.70	0.00	0.17
Fibroblast - Dermal, donor1	11269-116G9	24.89	13.85	3.76	1.41	3.52	1.64	0.47	0.47
Fibroblast - Dermal, donor2	11346-117G5	10.38	5.19	7.08	0.94	1.89	0.00	0.47	2.36
Fibroblast - Dermal, donor3	11418-118F5	27.92	10.28	5.32	2.06	3.26	1.21	0.73	0.73
Fibroblast - Dermal, donor4	11450-119A1	11.87	7.35	2.15	2.94	1.81	1.81	0.11	0.45
Fibroblast - Dermal, donor5	11454-119A5	14.31	8.72	4.19	2.27	1.57	2.44	0.00	0.52
Fibroblast - Dermal, donor6	11458-119A9	16.73	8.45	3.74	2.27	1.62	2.11	0.00	0.97
Fibroblast - Gingival, donor1	11237-116D4	30.40	10.62	5.21	3.54	3.33	1.25	0.62	0.62
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	40.87	17.03	6.55	3.67	1.31	1.05	0.26	0.26
Fibroblast - Gingival, donor2	11318-117D4	20.43	8.17	4.22	2.37	2.24	0.92	0.40	0.40
Fibroblast - Gingival, donor3	11394-118C8	18.27	6.19	2.32	1.06	3.19	1.84	0.19	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	33.24	22.86	10.39	5.19	5.19	0.00	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	40.35	22.03	4.41	3.52	5.99	1.59	1.59	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	46.30	17.62	9.51	3.27	1.87	1.56	0.16	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	20.01	8.93	5.14	1.49	1.49	0.95	0.41	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	15.17	8.12	1.76	1.76	2.12	1.41	0.00	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	21.06	7.02	2.34	2.05	1.02	1.17	0.44	0.58
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	15.41	5.59	2.32	1.50	0.95	0.68	0.00	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	26.11	8.12	3.95	3.07	2.08	0.77	0.00	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	30.52	13.94	3.23	2.49	1.91	1.91	0.15	1.03
Fibroblast - Lung, donor1	11270-116H1	12.23	8.16	2.72	0.00	0.00	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	14.92	1.49	5.97	0.00	1.49	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	18.57	8.86	2.53	2.74	3.17	0.21	0.42	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	4.17	2.50	2.50	0.83	0.83	1.67	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	1.40	0.00	0.00	1.40	0.00	0.00	1.40	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	1.96	1.68	0.56	0.00	0.00	0.28	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	12.99	7.71	4.47	1.62	1.62	0.41	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	0.00	3.99	3.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	17.87	5.96	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	19.40	5.43	3.49	2.91	1.36	2.33	0.58	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	21.84	13.04	4.55	3.03	2.73	1.97	0.00	0.46
Fibroblast - Periodontal Ligament, donor3	11395-118C9	56.30	21.11	10.40	6.12	6.73	3.37	1.22	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	26.71	9.92	8.40	2.29	4.20	0.76	0.00	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	33.21	17.82	5.67	1.35	2.70	1.62	0.00	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	53.00	28.65	7.19	6.26	11.71	2.90	0.35	0.81
Fibroblast - Pulmonary Artery, donor1	11250-116E8	26.42	12.60	9.28	3.21	2.32	1.11	1.44	1.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	20.32	7.72	3.05	0.81	1.02	0.61	0.20	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	3.34	1.34	1.34	0.00	0.67	0.67	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	7.91	2.37	2.37	0.40	1.19	0.79	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	32.35	13.69	5.56	1.98	1.19	0.40	0.60	1.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	24.33	11.72	3.20	2.31	2.31	2.13	0.00	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	38.23	20.30	4.53	5.12	2.56	2.37	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	19.86	12.03	7.22	2.11	0.00	0.60	0.60	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	31.41	22.78	5.72	2.91	2.27	2.59	0.76	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	20.75	17.97	5.06	1.77	0.76	0.25	0.51	1.27
Fibroblast - skin normal, donor1	11553-120C5	14.77	9.52	2.30	2.95	1.97	0.98	0.16	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	29.68	12.43	6.02	2.41	1.60	1.20	0.20	0.80
Fibroblast - skin normal, donor2	11561-120D4	26.32	17.18	6.13	3.42	3.21	3.11	0.20	1.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	35.06	24.78	7.86	3.02	0.60	1.21	0.00	1.21
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	29.08	12.84	2.90	4.06	2.24	0.99	0.25	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	26.33	16.41	5.30	2.39	3.42	2.91	0.17	1.88
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	15.76	17.74	6.57	2.30	0.66	0.00	1.97	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	18.43	15.34	6.28	2.34	2.45	1.38	0.85	1.38
Fibroblast - skin walker warburg, donor1	11554-120C6	13.33	8.10	3.88	2.70	2.53	0.84	0.17	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	10.66	6.74	1.57	1.10	0.94	0.31	0.00	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	132.96	22.16	0.00	0.00	22.16	22.16	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	0.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	16.12	9.88	3.64	2.95	2.43	1.39	0.00	0.69
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	34.87	13.27	4.94	4.68	3.12	1.30	0.52	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	26.32	15.33	7.67	5.62	2.56	1.02	0.51	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	21.44	3.83	0.00	3.83	2.30	3.83	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	16.59	5.74	0.64	5.10	1.91	0.64	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	40.51	9.13	3.14	3.99	5.99	2.00	1.14	0.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	17.65	7.45	0.28	3.03	1.65	2.48	0.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	15.98	9.59	0.91	3.88	1.37	0.91	0.23	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	29.32	9.11	2.77	5.55	4.56	3.17	0.59	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	12.69	6.08	0.26	1.32	1.59	1.59	0.00	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	23.81	9.78	0.98	2.28	1.63	1.30	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	16.80	6.19	1.33	2.65	5.31	4.42	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	12.72	4.95	0.71	2.97	1.98	2.40	0.14	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	14.41	8.13	1.35	2.59	3.82	2.09	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	22.30	8.86	0.81	2.95	3.49	0.81	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	20.57	9.91	0.62	2.11	3.35	1.98	0.25	0.74
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	20.63	9.83	2.77	1.94	4.29	2.35	0.14	0.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	15.86	7.73	1.63	1.42	1.83	1.63	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	14.15	6.16	1.37	1.60	1.83	1.37	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	13.45	5.36	1.99	1.74	2.12	1.12	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	18.14	8.74	1.75	2.62	2.62	0.87	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	11.23	5.91	2.07	2.07	2.66	1.18	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	13.67	6.04	1.27	2.23	3.50	1.91	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	11.17	6.03	2.23	3.13	2.68	1.34	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	12.30	4.03	1.21	1.41	2.42	1.01	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	14.59	6.96	1.87	2.54	2.71	2.04	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	15.96	7.63	3.10	3.37	2.22	1.95	0.09	0.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	14.46	8.32	1.77	2.81	2.29	2.91	0.42	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	14.00	6.83	1.37	2.39	1.88	2.22	0.17	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	13.17	5.53	1.33	1.66	3.65	1.22	0.22	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	15.47	4.99	1.75	2.50	1.83	2.00	0.17	0.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	11.64	7.15	2.25	2.86	2.25	1.23	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	9.70	4.33	1.65	1.24	2.89	1.86	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	11.07	5.88	1.61	1.84	3.00	1.73	0.00	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	10.84	6.67	1.00	1.67	1.83	0.67	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	8.16	5.07	0.88	1.32	1.10	0.88	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	11.68	5.66	0.86	1.84	2.58	2.21	0.12	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	11.35	6.65	1.30	3.08	2.11	0.97	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	6.74	5.13	0.00	1.28	1.60	1.28	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	9.85	5.40	1.33	1.80	1.52	1.42	0.09	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	6.96	3.32	0.63	0.63	1.90	0.47	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	8.51	3.04	0.91	0.61	1.82	1.22	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	10.87	5.75	2.20	1.05	2.82	0.63	0.21	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	7.68	4.61	0.88	0.44	1.76	1.32	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	11.22	5.61	1.40	1.68	2.52	0.28	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	11.02	4.17	1.39	1.94	2.04	1.11	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	9.89	1.60	1.34	0.80	0.27	0.80	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	7.96	5.36	0.61	1.68	0.77	0.77	0.15	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	9.59	4.66	1.94	1.42	1.94	0.52	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	8.67	2.98	1.63	0.54	1.08	0.81	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	12.17	6.64	2.40	1.66	1.66	0.92	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	14.69	7.90	1.75	1.97	1.54	0.44	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	10.91	7.93	0.99	2.98	1.98	0.99	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	20.31	9.89	2.11	1.85	2.37	1.06	0.26	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	15.33	6.66	1.41	1.41	0.61	1.01	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	26.69	13.98	3.05	4.07	3.56	2.80	0.00	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	30.06	18.31	3.38	4.38	3.78	5.18	0.00	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	20.65	10.63	1.39	3.54	6.16	3.54	0.00	0.62
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	22.91	9.82	2.45	4.30	5.11	3.07	0.00	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	14.39	0.63	0.00	1.56	1.88	1.56	0.63	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	8.48	1.70	0.57	1.41	0.28	0.28	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	15.68	4.61	0.92	1.84	2.31	1.84	0.46	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	7.42	0.00	7.42	0.00	4.95	4.95	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	13.54	2.32	0.77	1.16	1.55	1.55	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	20.86	4.81	0.00	1.60	4.81	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	19.13	0.00	0.00	1.74	3.48	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	9.44	3.25	1.30	1.30	0.98	0.98	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	13.18	5.35	2.47	1.65	0.41	2.06	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	10.00	6.66	0.00	0.00	3.33	6.66	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	10.35	1.96	1.68	2.24	2.80	1.68	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	8.50	1.31	0.33	2.29	2.29	0.98	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	10.90	5.03	0.00	1.68	4.19	0.84	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	7.00	4.13	0.32	0.95	1.91	0.95	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	9.85	3.40	1.02	1.02	1.70	1.02	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	6.26	0.00	0.00	0.00	4.18	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	8.02	4.01	0.57	1.15	3.44	1.15	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	6.81	2.96	0.00	0.30	0.30	0.30	0.00	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	8.47	1.69	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	10.36	2.90	1.66	1.24	1.24	0.41	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	10.59	2.76	0.69	0.69	0.69	1.38	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	5.27	5.27	5.27	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	10.38	2.31	0.00	2.31	0.00	0.38	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	7.82	4.24	0.65	1.96	0.33	0.98	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	8.69	7.36	0.67	0.67	0.67	0.67	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	18.49	4.62	1.16	1.93	3.08	2.31	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	11.64	4.11	1.37	0.68	1.37	0.68	0.68	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	9.94	4.97	2.48	0.00	2.48	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	7.55	4.72	1.89	1.42	1.89	3.30	0.00	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	7.24	3.02	0.00	1.81	1.21	1.81	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	9.66	4.07	1.53	2.03	1.53	1.02	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	11.17	4.79	0.80	1.20	2.39	0.80	0.00	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	8.39	3.95	1.97	2.96	4.44	0.49	0.00	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	14.17	11.80	1.18	1.18	2.36	1.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	12.25	5.25	2.33	1.17	4.67	1.17	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	8.78	8.34	1.76	1.32	3.07	1.76	0.00	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	5.09	5.93	0.85	1.70	0.85	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	4.78	0.60	2.39	1.19	1.79	1.19	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	7.76	2.43	0.97	1.46	0.49	1.46	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	11.41	4.57	3.42	1.14	1.14	0.00	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	12.06	3.74	2.91	0.00	1.25	0.42	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	9.00	2.25	1.12	2.25	0.00	2.25	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	16.18	9.20	2.22	1.59	1.59	1.59	0.95	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	15.04	6.27	1.25	0.42	2.09	0.84	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	4.64	3.13	0.46	1.51	0.81	1.04	0.00	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	5.57	2.36	0.34	2.03	0.68	0.17	0.00	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	2.50	2.73	0.68	2.28	0.68	0.23	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	3.28	1.75	0.66	1.53	0.98	0.66	0.00	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	4.94	4.94	0.43	2.58	0.86	0.43	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	3.66	1.94	0.43	2.15	0.43	0.43	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	3.49	2.74	0.25	2.24	0.50	0.87	0.00	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	3.95	2.40	0.00	1.37	1.03	1.20	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	2.88	2.56	0.00	0.96	0.32	0.32	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	3.92	2.80	5.60	0.00	0.00	0.00	1.12	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	3.03	2.60	0.87	0.00	0.43	0.00	1.30	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	10.58	2.64	18.51	0.00	0.00	0.00	5.29	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	4.94	3.88	2.47	1.76	0.71	0.71	0.35	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	6.54	1.45	1.45	0.00	0.00	1.45	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	17.83	9.27	6.12	1.22	1.75	0.00	0.35	0.35
Hepatocyte, donor1	11523-119I2	7.26	1.21	0.00	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	9.70	3.23	1.08	1.08	0.00	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	8.59	4.29	1.23	1.23	0.00	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	10.31	5.59	0.35	2.10	0.87	1.40	0.00	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	58.86	22.78	17.01	2.47	3.29	1.10	0.96	0.96
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	9.55	0.00	0.00	0.00	0.00	0.00	0.00	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	6.92	2.77	0.00	1.38	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	5.01	2.50	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	7.69	0.00	0.00	0.00	0.00	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	4.87	1.62	0.00	1.62	1.62	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	3.33	1.67	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	3.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	5.29	0.00	1.32	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	2.22	1.11	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	2.52	1.89	0.00	0.00	0.63	0.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	3.09	3.09	1.55	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	0.00	0.00	0.00	0.00	0.00	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	7.75	0.65	0.65	0.00	0.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	3.22	1.61	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	6.52	1.63	0.00	0.00	0.00	0.00	0.00	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	2.10	0.84	0.00	2.10	0.42	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	14.37	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	4.02	3.21	0.80	0.00	0.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	5.54	0.92	0.00	1.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	4.25	0.94	0.00	0.94	0.00	0.94	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	4.53	0.91	0.00	0.00	0.91	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	5.38	0.00	1.08	3.23	1.08	1.08	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	6.35	1.27	1.27	1.27	0.00	1.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	16.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	4.46	0.64	0.64	0.00	0.00	0.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	0.00	0.00	1.82	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	5.00	1.43	0.71	0.00	0.71	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	3.32	3.32	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	3.70	1.23	0.00	0.31	0.31	0.31	0.00	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	8.78	3.51	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	3.14	3.14	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	5.56	6.26	0.00	2.09	0.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	2.21	2.21	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	6.48	0.00	3.24	3.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	0.87	1.74	0.00	0.00	0.87	0.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	2.25	0.00	0.00	0.00	2.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	4.27	1.07	0.00	1.07	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	2.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	2.85	0.00	0.00	0.00	0.00	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	3.68	0.92	0.00	0.00	0.00	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	0.00	0.00	3.03	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	3.17	1.06	0.00	1.06	2.11	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	7.02	5.71	1.14	2.37	1.06	0.90	0.08	0.08
Keratinocyte - epidermal, donor2	11349-117G8	0.59	2.34	0.00	1.17	0.59	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	6.63	4.92	1.04	1.99	1.70	1.70	0.00	0.00
Keratinocyte - oral, donor1	11251-116E9	13.05	9.31	1.93	2.84	1.93	2.50	0.00	0.34
Keratocytes, donor1	11527-119I6	5.85	0.69	0.69	0.00	1.38	0.34	0.00	0.00
Keratocytes, donor2	11607-120I5	5.86	2.34	2.34	0.00	1.17	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	10.08	3.95	1.78	1.19	1.38	0.99	0.00	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	21.98	2.20	0.00	4.40	2.20	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	45.31	12.94	8.63	2.16	4.31	1.08	3.24	1.08
Lens Epithelial Cells, donor2	11609-120I7	34.48	13.72	5.88	2.88	3.11	1.27	0.58	0.81
Lens Epithelial Cells, donor3	11690-122I7	65.79	32.80	17.46	3.94	3.83	0.61	2.83	1.11
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	16.72	6.40	30.00	0.83	1.42	0.24	9.37	2.73
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	6.70	3.63	12.84	0.28	0.56	0.00	4.19	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	16.69	7.71	36.05	1.57	2.20	0.79	12.75	3.94
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	10.22	3.23	18.28	0.00	1.61	0.00	10.22	1.61
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	7.56	1.58	6.30	0.00	0.00	0.00	2.52	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	6.36	1.83	13.26	0.32	0.65	0.22	6.15	1.62
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	9.44	5.75	23.80	1.23	0.41	0.41	12.31	3.28
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	4.30	0.76	7.33	2.02	0.00	0.00	3.54	1.77
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	7.74	4.36	13.65	0.84	0.70	0.28	6.76	2.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	11.87	5.93	15.03	0.79	1.19	0.40	5.93	1.98
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	7.76	2.71	12.02	1.55	0.19	0.00	5.04	2.13
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	4.26	1.30	7.59	0.19	0.19	0.19	3.33	1.11
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	11.85	5.23	20.21	1.05	1.05	0.00	9.76	1.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	5.25	1.91	9.54	0.48	0.48	0.24	4.77	0.72
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	6.04	2.47	11.26	0.41	0.55	0.00	3.85	1.24
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	16.32	6.78	19.71	0.92	0.62	0.31	8.31	2.77
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	2.49	2.81	9.04	0.31	0.62	0.00	2.18	1.25
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	6.77	2.56	14.82	0.91	0.18	0.55	6.04	1.28
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	14.81	3.29	17.11	2.63	0.66	0.00	11.85	2.63
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	4.98	1.17	7.32	0.29	0.88	0.59	2.64	0.88
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	5.73	1.49	8.21	1.00	0.00	0.25	3.49	0.75
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	13.09	7.27	23.76	1.45	0.48	0.48	11.15	3.39
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	6.73	4.31	14.81	1.08	0.27	0.27	5.39	1.35
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	7.72	4.09	13.78	0.30	0.76	0.15	6.21	1.51
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	10.89	2.59	14.00	1.04	0.00	0.52	7.78	2.07
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	11.10	5.03	19.26	0.84	1.05	0.00	7.12	1.88
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	5.56	3.46	10.98	0.45	0.60	0.30	4.36	1.20
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	8.25	4.13	13.07	0.00	1.38	0.69	6.19	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	6.96	5.08	11.67	0.75	0.38	0.00	3.39	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	5.09	2.76	11.35	0.74	0.21	0.11	3.18	0.95
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	8.24	4.36	18.90	0.97	0.97	0.48	6.30	1.94
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	5.62	2.65	9.59	0.66	0.00	0.33	0.99	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	4.21	1.98	12.27	0.87	0.87	0.12	3.96	1.61
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	17.77	8.51	29.99	1.11	0.74	0.74	14.44	3.33
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	7.17	3.21	13.84	0.74	1.24	0.00	4.20	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	4.81	2.47	10.17	0.27	0.27	0.00	2.20	1.65
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	16.08	6.11	25.09	1.93	0.96	0.32	9.33	3.54
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	17.35	4.26	19.17	0.61	0.91	0.61	3.35	3.65
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	12.60	4.34	20.44	0.84	0.56	0.14	7.42	2.10
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	12.44	6.04	20.62	0.00	0.71	0.00	11.73	2.13
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	6.79	1.94	5.33	0.97	0.97	0.00	2.91	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	4.82	2.65	8.25	0.62	0.47	0.16	4.05	1.24
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	9.67	6.80	12.89	1.43	0.00	0.00	7.52	1.79
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	7.19	5.23	7.84	0.65	0.33	0.98	2.94	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	2.83	0.71	5.89	0.00	0.00	0.24	4.24	0.71
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	16.09	4.58	30.32	1.86	1.24	0.74	5.57	3.22
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	3.59	2.05	7.94	0.51	0.51	0.26	1.79	2.31
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	6.86	4.77	8.65	0.60	1.19	0.00	5.37	1.79
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	2.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	0.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	0.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	0.00	0.42	0.00	0.42	0.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	0.00	0.00	0.00	0.00	0.00	0.70	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	0.00	0.00	1.19	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	0.45	0.23	0.00	0.00	0.23	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	0.29	0.00	0.00	0.00	0.29	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	0.90	0.00	0.00	0.45	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	0.54	0.14	0.00	0.00	0.27	0.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	0.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	0.35	0.35	0.00	0.71	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	0.00	0.00	0.00	0.67	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	0.00	0.51	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	0.80	0.53	0.00	0.00	0.00	0.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	0.94	0.19	0.19	0.19	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	1.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	0.82	0.82	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	1.04	0.42	0.00	0.21	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	0.28	0.84	0.00	0.28	0.28	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	1.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	0.87	0.58	0.00	0.00	0.29	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	0.30	0.00	0.30	0.30	0.00	0.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	0.55	1.66	0.00	1.11	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	0.71	0.00	0.35	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	0.00	0.37	0.00	0.37	0.00	0.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	1.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	0.38	0.00	0.00	0.77	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	0.00	0.00	0.00	1.13	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	0.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	2.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	0.00	0.75	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	0.37	0.00	0.00	0.37	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	1.29	0.43	0.00	0.43	0.00	0.43	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	1.33	0.33	0.00	0.00	0.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	0.71	0.71	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	1.03	0.34	0.34	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	0.00	0.00	0.00	0.54	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	0.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	1.11	0.74	0.37	0.74	0.00	0.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	0.00	1.06	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	0.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	0.00	0.73	0.00	0.73	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	0.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	0.49	0.00	0.00	0.49	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	0.94	0.94	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	0.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	0.45	0.45	0.00	0.45	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	0.00	0.00	0.00	1.72	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	0.45	0.45	0.89	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	0.00	0.00	0.39	0.00	0.00	0.39	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	1.04	0.52	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	0.00	0.00	0.00	0.00	0.00	0.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	0.56	0.56	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	0.88	0.44	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	0.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	0.51	0.51	0.00	0.51	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	1.92	0.96	0.00	0.00	0.48	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	1.99	1.19	0.00	0.00	0.00	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	0.00	1.38	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	0.76	0.00	0.00	0.00	0.00	0.76	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	0.52	1.55	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	0.60	0.60	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	1.90	0.00	0.00	0.00	0.32	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	0.53	1.07	1.07	0.00	0.00	0.00	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	0.00	1.15	0.57	1.15	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	1.54	1.54	0.00	0.51	0.51	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	0.00	1.41	0.00	0.71	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	1.13	0.57	0.00	0.00	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	1.66	0.83	0.42	0.42	0.00	0.83	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	0.00	1.57	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	0.42	0.00	0.00	0.00	0.00	0.84	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	0.93	0.46	0.00	0.46	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	1.34	0.00	0.00	1.34	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	0.00	0.53	0.00	0.00	0.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	0.81	1.21	0.81	0.81	0.40	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	2.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	3.56	0.00	0.00	0.89	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	0.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	0.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	1.34	0.00	0.45	0.00	0.00	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	0.78	0.52	0.00	0.26	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	0.68	0.00	0.91	0.68	0.00	0.23	0.00	0.23
Macrophage - monocyte derived, donor2	11313-117C8	11.01	2.57	2.57	1.10	0.92	0.18	0.00	0.18
Macrophage - monocyte derived, donor3	11389-118C3	9.70	4.46	1.97	0.79	0.66	0.13	0.26	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	15.40	8.50	5.31	2.12	1.06	1.06	0.00	1.06
Mallassez-derived cells, donor2	11929-125I3	48.80	23.13	8.56	4.91	1.90	0.63	0.79	0.63
Mallassez-derived cells, donor3	11930-125I4	39.33	19.04	6.12	3.20	3.06	1.53	1.39	1.11
Mammary Epithelial Cell, donor1	11273-116H4	14.75	9.57	3.19	3.79	1.59	2.09	0.10	0.90
Mammary Epithelial Cell, donor2	11350-117G9	13.03	5.50	1.45	4.05	2.03	1.16	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	3.99	3.49	0.00	0.25	0.50	0.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	46.10	4.75	42.71	0.68	1.36	0.00	0.00	5.42
Mast cell, donor1	11563-120D6	5.62	0.97	6.16	0.32	0.00	0.32	0.11	1.30
Mast cell, donor2	11565-120D8	10.70	2.38	10.70	1.19	0.30	0.59	0.59	2.08
Mast cell, donor3	11566-120D9	11.71	2.03	12.83	1.13	2.48	1.58	0.68	2.70
Mast cell, donor4	11567-120E1	5.85	2.30	6.21	0.35	0.18	0.35	0.18	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	5.77	0.89	5.21	0.55	0.22	0.33	0.33	0.78
Mast cell, expanded and stimulated, donor8	11942-126A7	4.67	0.00	4.67	0.58	0.00	0.00	0.58	0.58
Mast cell, expanded, donor5	11939-126A4	3.44	1.03	6.42	0.00	0.00	0.46	0.11	1.38
Mast cell, expanded, donor8	11941-126A6	1.84	0.33	4.18	0.17	0.00	0.00	0.33	1.34
Melanocyte - dark, donor1	11502-119F8	16.62	9.35	25.17	1.39	2.29	0.60	6.17	4.08
Melanocyte - dark, donor2	11582-120F7	9.00	5.88	4.50	0.35	0.00	1.04	0.69	0.35
Melanocyte - dark, donor3	11663-122F7	13.69	6.66	1.59	2.03	2.32	1.59	0.07	0.29
Melanocyte - light, donor1	11274-116H5	6.11	2.59	0.94	0.71	0.71	0.47	0.00	0.00
Melanocyte - light, donor2	11351-117H1	2.73	4.09	0.68	0.68	0.68	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	2.60	2.60	0.87	0.87	0.00	1.73	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	16.24	11.66	1.77	2.92	3.54	1.56	0.10	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	10.49	5.65	1.88	1.88	2.15	1.88	0.00	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	17.41	7.50	2.68	1.61	1.34	2.68	0.00	0.00
Meningeal Cells, donor1	11493-119E8	8.68	3.23	9.18	0.50	0.87	0.37	0.25	1.49
Meningeal Cells, donor2	11573-120E7	11.88	3.08	5.28	0.44	0.88	0.44	0.88	1.32
Meningeal Cells, donor3	11654-122E7	22.01	3.75	12.96	1.71	1.14	1.22	0.41	1.39
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	11.69	3.42	1.71	1.14	2.00	1.14	0.57	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	40.35	20.73	12.28	3.72	2.62	1.01	2.21	1.41
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	2.63	1.31	0.00	0.00	0.00	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	1.31	1.31	1.31	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	27.27	12.92	7.18	4.31	0.72	0.72	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	65.22	32.82	12.92	5.72	3.60	2.12	0.64	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	31.16	19.10	4.02	2.51	3.52	0.50	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	5.93	1.32	1.32	0.22	0.88	1.32	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	4.38	1.46	0.73	0.73	1.46	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	5.32	2.05	2.46	1.02	1.02	0.41	0.20	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	22.99	10.67	6.37	2.91	2.35	1.39	0.83	0.83
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	4.09	0.37	0.00	0.00	0.37	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	36.05	15.13	8.16	2.24	2.24	1.32	0.92	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	8.01	2.67	1.48	0.00	0.30	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	9.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	4.48	4.48	1.92	2.56	1.92	1.28	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	42.18	13.47	8.51	3.54	2.13	2.13	0.35	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	38.15	16.89	5.94	3.75	3.13	0.31	0.63	1.56
Mesenchymal stem cells - umbilical, donor0	11214-116A8	22.50	13.06	8.71	2.90	1.45	0.73	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	53.83	28.90	8.22	4.24	2.92	0.53	1.86	0.53
Mesothelial Cells, donor2	12156-128G5	31.53	22.02	4.00	2.50	3.00	0.50	2.00	0.00
Mesothelial Cells, donor3	11402-118D7	56.94	23.70	8.82	2.89	2.96	0.65	1.88	0.51
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	64.82	21.61	6.75	2.70	1.35	1.35	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	32.26	7.14	6.16	1.23	0.74	0.74	0.49	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	19.43	6.48	3.83	1.18	0.00	0.88	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	44.94	6.91	13.83	0.00	0.00	3.46	0.00	3.46
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	18.60	3.41	6.20	0.31	0.62	0.31	0.62	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	17.42	3.32	2.28	1.66	0.83	0.00	0.21	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	34.74	16.21	4.63	2.32	2.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	23.52	8.26	5.51	1.25	0.50	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	24.67	4.19	4.19	0.47	0.47	0.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	77.86	38.93	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	21.34	4.47	5.08	1.02	0.81	0.41	0.41	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	17.82	4.75	5.94	1.58	0.00	0.40	0.79	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	42.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	11.50	2.65	2.65	0.00	0.00	0.00	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	8.36	2.66	1.90	2.28	0.38	0.00	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	32.90	3.95	0.00	0.00	1.32	0.00	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	14.64	3.40	2.76	0.21	0.21	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	18.42	6.45	1.84	0.92	0.00	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	13.71	6.26	3.28	0.30	1.19	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	26.83	13.41	1.68	1.68	1.68	0.00	0.00	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	101.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	11.04	3.51	1.76	0.50	0.25	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	9.74	3.57	1.66	1.19	0.24	0.00	0.48	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	17.14	5.53	2.21	0.00	0.55	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	12.43	2.30	2.99	0.46	0.00	0.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	12.83	1.05	1.89	0.21	0.42	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	10.19	3.06	2.24	0.20	0.20	0.20	0.20	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	12.66	3.00	3.86	0.43	0.00	0.43	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	12.89	3.11	2.22	0.89	0.67	0.67	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	30.96	20.64	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	9.86	3.29	2.41	0.22	0.22	0.00	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	12.17	5.07	2.03	0.51	0.51	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	9.94	3.31	0.00	3.31	1.66	0.00	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	14.13	2.72	5.44	1.90	0.27	0.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	10.29	2.65	1.76	0.59	1.18	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	10.90	1.09	0.00	1.09	1.09	0.00	1.09	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	5.29	1.44	1.44	0.00	0.48	0.48	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	10.41	2.00	2.40	0.40	0.00	0.00	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	9.60	1.37	0.00	0.00	0.00	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	6.51	1.50	0.50	0.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	16.31	2.04	2.04	2.04	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	11.39	0.88	0.88	0.44	0.44	0.44	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	18.76	4.41	1.10	1.10	0.00	0.00	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	14.09	5.76	0.00	0.00	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	9.67	4.71	0.50	0.25	0.50	0.50	0.00	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	9.74	1.39	1.39	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	15.47	2.21	0.00	2.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	10.60	3.76	0.68	0.34	0.34	0.34	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	17.50	5.69	2.63	0.44	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	8.17	4.97	1.78	1.07	1.07	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	9.54	3.09	2.52	0.84	0.84	0.28	0.00	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	12.05	2.49	1.25	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	9.32	5.83	1.17	1.75	0.00	0.58	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	10.56	2.41	0.90	0.30	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	7.51	3.34	1.67	1.67	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	28.88	7.22	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	10.16	3.69	1.85	0.92	0.00	0.92	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	7.40	5.69	0.57	0.57	0.57	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	6.36	2.90	2.07	0.69	0.69	0.28	0.00	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	6.74	3.11	1.04	0.26	0.52	0.78	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	12.01	3.00	2.57	0.86	0.43	0.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	7.62	3.81	1.91	0.64	1.27	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	6.94	6.41	1.87	0.80	1.07	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	11.97	5.69	2.10	1.20	0.90	0.30	0.60	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	6.50	4.10	1.98	0.00	0.14	0.28	0.00	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	5.73	5.10	0.64	1.27	0.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	7.52	4.86	1.33	1.33	0.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	6.07	3.41	1.14	0.76	0.76	0.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	8.81	7.10	1.14	0.57	0.28	0.28	0.28	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	10.08	5.41	0.74	0.49	0.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	14.99	8.47	1.96	1.30	0.65	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	14.70	9.11	2.06	0.59	1.18	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	15.57	6.34	1.44	1.15	1.44	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	20.20	6.59	4.53	2.47	0.82	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	16.68	7.74	3.87	0.89	0.60	0.30	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	0.00	0.00	0.00	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	1.78	1.78	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	3.16	0.00	0.00	0.00	0.00	1.05	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	0.79	0.20	0.20	0.40	0.00	0.20	0.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	7.45	1.86	1.86	0.00	0.93	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	0.38	0.38	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	0.27	0.80	0.27	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	0.90	0.68	0.57	0.45	0.00	0.23	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	0.74	0.00	0.74	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	0.00	0.00	0.00	0.53	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	0.00	3.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	0.42	0.84	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	0.00	1.36	1.36	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.91	1.91	0.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	5.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	19.57	3.26	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	0.00	4.75	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	24.13	13.14	7.97	2.15	1.94	1.08	0.22	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	12.54	9.41	2.09	3.14	4.70	1.05	1.57	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	19.36	11.35	3.34	2.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	16.28	9.18	0.42	0.83	1.67	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	28.52	11.60	4.18	1.71	1.90	0.95	0.38	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	52.66	35.11	1.60	9.58	6.38	1.60	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	6.12	8.16	2.04	0.00	0.00	1.36	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	71.67	27.56	9.19	3.68	1.84	1.84	1.84	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	9.63	6.28	0.84	1.26	1.26	0.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	22.55	11.16	2.56	0.70	0.93	0.46	0.46	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	9.19	4.05	2.16	1.08	1.35	1.35	0.00	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	14.09	7.99	3.36	2.10	0.42	0.42	0.00	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	11.13	22.27	11.13	0.00	0.00	0.00	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	6.45	5.46	2.48	0.50	1.49	1.49	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	11.64	4.60	1.08	0.54	0.81	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	12.01	8.61	0.91	0.91	1.36	0.23	0.23	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	8.98	5.06	2.45	1.14	0.82	0.49	0.49	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	15.67	7.29	2.37	1.09	0.73	0.91	0.00	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	5.83	4.77	0.00	0.53	1.06	0.53	0.00	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	4.20	1.80	1.20	0.00	1.20	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	22.97	10.17	1.64	1.31	0.33	0.66	0.33	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	7.97	7.16	1.30	1.46	1.79	0.33	0.49	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	16.76	9.70	1.76	1.59	1.06	0.88	0.35	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	4.22	2.81	0.00	0.70	0.00	0.00	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	8.73	2.30	0.46	0.46	0.46	0.92	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	9.64	7.39	0.00	0.96	0.96	0.32	0.32	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	31.04	13.80	1.72	1.72	1.72	1.03	0.69	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	108.72	58.15	15.17	5.06	10.11	0.00	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	17.82	8.02	2.45	2.23	0.67	1.11	0.45	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	6.77	5.93	1.27	1.27	1.27	0.85	0.42	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	8.07	3.80	0.24	0.71	0.71	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	9.01	8.16	2.58	0.86	2.58	0.43	0.43	1.29
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	117.36	81.25	9.03	27.08	18.06	9.03	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	10.00	6.33	2.00	1.33	1.67	1.00	0.67	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	14.88	8.57	1.80	1.80	3.61	1.35	0.90	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	3.97	3.57	0.79	1.19	0.40	0.40	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	3.71	2.79	1.86	0.93	0.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	17.03	10.59	1.89	1.51	1.14	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	12.71	11.73	1.30	2.61	2.61	0.98	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	8.72	6.97	0.87	1.31	2.61	1.74	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	19.90	16.73	2.71	2.71	2.26	3.62	0.45	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	5.29	7.94	0.00	0.88	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	7.98	2.66	0.66	1.33	0.66	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	10.91	5.95	2.48	0.99	1.49	1.49	0.99	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	6.51	6.51	0.77	0.77	1.15	0.38	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	23.29	7.86	0.91	1.21	0.91	0.91	0.00	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	16.36	11.27	1.55	2.43	2.43	0.66	0.66	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	4.07	3.39	0.68	0.00	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	15.33	5.11	0.00	5.11	10.22	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	10.97	7.32	0.61	0.61	0.61	0.61	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	14.16	10.70	1.26	0.63	3.78	0.00	0.00	0.94
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	7.57	7.57	0.61	1.51	0.91	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	8.70	6.33	2.37	2.37	0.00	1.58	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	14.74	19.27	1.13	2.27	2.27	0.00	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	25.29	20.23	5.06	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	22.61	10.68	4.72	1.99	2.48	2.73	0.37	0.25
Myoblast, donor2	11322-117D8	31.65	11.32	4.79	3.26	2.49	1.92	0.38	0.58
Myoblast, donor3	11398-118D3	23.37	10.76	5.89	3.20	0.67	0.67	0.34	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	0.31	0.31	0.00	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	0.30	0.30	0.00	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	0.00	0.00	0.18	0.00	0.00	0.00	0.00	0.00
Neural stem cells, donor1	11275-116H6	9.44	5.08	1.09	1.81	0.36	0.00	0.00	0.00
Neural stem cells, donor2	11352-117H2	21.18	11.55	7.70	1.93	1.93	0.00	0.00	0.00
Neurons, donor1	11494-119E9	15.93	6.83	1.14	4.55	3.41	1.14	0.00	0.00
Neurons, donor2	11574-120E8	10.79	10.13	1.32	2.42	0.88	1.10	0.22	0.22
Neurons, donor3	11655-122E8	13.15	11.51	0.82	2.47	0.00	0.00	0.00	0.00
Neutrophils, donor1	11233-116C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	18.29	5.82	2.26	1.31	0.71	1.42	0.00	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	3.91	0.65	0.65	0.33	0.00	0.00	0.00	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	15.64	7.82	1.20	0.80	2.41	0.40	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	26.29	12.66	2.20	1.65	1.38	0.41	0.00	0.41
Olfactory epithelial cells, donor2	11934-125I8	25.48	14.19	2.75	1.16	1.45	0.58	0.14	0.43
Olfactory epithelial cells, donor3	11935-125I9	24.86	10.56	2.84	1.48	1.82	0.91	0.11	0.11
Olfactory epithelial cells, donor4	11936-126A1	29.51	19.28	3.02	3.21	2.73	0.88	0.49	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	40.92	20.46	4.21	3.61	5.42	0.00	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	11.91	8.93	1.28	2.34	2.98	0.85	0.21	0.00
Osteoblast - differentiated, donor2	11353-117H3	10.29	5.72	0.00	1.14	2.29	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	7.45	1.86	1.24	0.62	2.48	1.86	0.00	0.00
Osteoblast, donor1	11277-116H8	6.25	3.71	2.15	1.37	0.98	0.39	0.59	0.20
Osteoblast, donor2	11354-117H4	37.22	12.64	4.21	4.92	4.21	2.81	1.40	3.51
Osteoblast, donor3	11426-118G4	28.26	12.80	1.78	3.91	2.49	1.42	0.18	0.18
Pancreatic stromal cells, donor1	11249-116E7	27.80	12.89	2.78	3.29	3.37	1.77	0.59	0.51
Pericytes, donor1	11491-119E6	1.56	0.78	0.22	0.11	0.11	0.00	0.11	0.11
Pericytes, donor2	11571-120E5	1.13	0.00	0.68	0.91	0.00	0.45	0.00	0.00
Pericytes, donor3	11652-122E5	8.95	4.68	2.64	1.22	0.61	0.61	1.42	0.41
Perineurial Cells, donor1	11499-119F5	28.37	5.31	9.38	2.71	3.28	2.03	0.79	1.36
Perineurial Cells, donor2	11579-120F4	19.78	7.27	7.18	1.01	0.74	0.46	0.83	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	0.00	0.00	0.32	0.00	0.00	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	0.00	0.00	0.24	0.00	0.00	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	0.26	0.13	0.00	0.13	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor1	11278-116H9	1.20	0.72	0.48	0.72	0.24	0.24	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	5.54	4.44	2.22	2.22	0.00	1.11	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	3.73	1.96	0.20	0.79	0.39	0.00	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	10.44	7.28	1.90	1.27	0.95	1.27	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	9.57	5.82	2.25	2.81	2.06	0.56	0.19	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	33.68	22.06	8.88	4.70	1.96	0.39	0.39	0.65
Preadipocyte - breast, donor2	11328-117E5	16.44	15.54	2.93	2.03	4.50	0.68	0.00	0.23
Preadipocyte - omental, donor1	11468-119C1	15.24	8.31	2.56	2.88	1.49	1.28	0.32	0.11
Preadipocyte - omental, donor2	11329-117E6	20.95	9.17	3.49	1.75	3.49	2.18	0.00	0.44
Preadipocyte - omental, donor3	11403-118D8	23.64	11.60	3.29	4.44	5.16	1.00	0.29	0.57
Preadipocyte - perirenal, donor1	11469-119C2	7.87	7.87	0.00	0.00	0.98	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	29.48	14.43	8.29	1.23	2.46	0.31	1.23	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	62.86	25.85	8.32	3.72	2.66	3.54	0.35	0.89
Preadipocyte - subcutaneous, donor3	11428-118G6	51.09	24.52	4.60	5.11	3.75	1.70	0.68	0.51
Preadipocyte - visceral, donor1	11280-116I2	43.50	21.33	6.15	3.82	2.42	3.07	0.65	0.56
Preadipocyte - visceral, donor2	11357-117H7	41.42	15.19	4.60	3.68	2.30	1.38	0.00	0.46
Preadipocyte - visceral, donor3	11429-118G7	33.85	22.67	5.85	2.93	3.13	1.57	0.21	0.84
Prostate Epithelial Cells (polarized), donor1	11253-116F2	15.99	7.54	0.75	1.21	2.26	0.75	0.00	0.00
Prostate Epithelial Cells, donor2	11331-117E8	20.99	11.24	3.52	2.84	2.03	1.35	0.27	0.14
Prostate Epithelial Cells, donor3	11404-118D9	3.74	4.47	0.43	1.90	2.08	2.27	0.00	0.00
Prostate Stromal Cells, donor1	11254-116F3	28.82	10.71	3.76	2.62	1.71	1.25	0.68	0.46
Prostate Stromal Cells, donor2	11332-117E9	25.28	11.12	5.02	3.23	1.43	0.36	0.72	0.36
Prostate Stromal Cells, donor3	11405-118E1	25.86	11.16	3.23	2.29	1.77	0.94	0.42	0.63
Renal Cortical Epithelial Cells, donor1	11516-119H4	2.92	3.65	1.09	0.36	1.46	0.36	0.00	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	35.42	12.06	3.81	2.43	3.19	2.08	0.07	0.14
Renal Epithelial Cells, donor1	11517-119H5	7.61	5.07	0.00	0.51	1.01	1.52	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	11.38	4.27	0.71	2.13	1.42	0.71	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	42.03	13.02	5.50	2.96	2.96	2.75	0.74	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	2.72	1.36	6.13	0.00	0.00	0.00	2.04	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	3.64	2.96	8.62	0.27	0.54	0.00	4.31	1.75
Renal Glomerular Endothelial Cells, donor3	11675-122H1	38.85	14.87	18.43	2.00	2.44	1.33	8.44	1.55
Renal Glomerular Endothelial Cells, donor4	11783-124B1	1.33	0.00	1.33	0.00	0.00	0.00	5.32	2.00
Renal Mesangial Cells, donor1	11518-119H6	9.46	4.40	0.66	0.88	1.32	0.00	0.00	0.44
Renal Mesangial Cells, donor2	11598-120H5	3.13	6.90	1.25	1.88	1.25	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	4.44	4.16	0.00	0.28	0.55	0.28	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	13.42	4.03	3.22	0.54	0.81	0.81	0.27	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	6.75	1.69	0.42	0.84	0.84	0.42	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	8.87	5.79	1.54	1.16	0.77	0.39	0.00	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	39.41	18.67	4.93	3.37	4.15	1.81	0.00	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	9.38	3.41	2.56	0.57	0.85	0.28	0.00	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	2.06	4.12	0.00	1.03	0.00	0.00	0.00	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	22.83	9.53	3.01	2.01	1.25	1.00	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	32.47	22.05	4.01	5.75	5.08	1.20	0.67	0.80
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	6.25	0.89	0.89	0.00	1.79	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	10.46	0.55	0.00	1.10	0.00	0.55	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	16.82	8.12	1.16	2.32	1.16	1.16	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	17.42	6.11	2.08	1.56	0.91	1.82	0.00	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	12.61	2.98	1.49	2.09	0.70	0.79	0.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	13.94	4.91	1.67	3.23	1.23	0.67	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	18.85	6.70	2.11	3.23	0.37	0.87	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	10.96	4.31	1.52	1.52	0.93	1.17	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	12.48	6.47	1.85	1.85	1.16	1.16	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	13.83	5.48	1.78	2.33	1.10	0.96	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	12.86	4.39	1.36	1.06	0.76	1.66	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	15.05	6.63	2.15	3.40	0.72	2.15	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	11.05	5.16	2.30	2.44	1.29	0.72	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	10.52	4.40	1.50	1.72	0.75	0.97	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	12.17	2.66	1.99	1.33	0.89	0.22	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	11.66	6.12	2.10	0.57	0.76	1.72	0.19	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	13.51	5.03	0.84	2.24	0.75	0.65	0.00	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	14.09	6.01	2.25	5.07	0.19	1.50	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	14.07	7.56	2.39	1.46	1.46	1.33	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	13.53	5.16	0.78	2.34	1.36	1.56	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	10.31	4.39	0.38	1.72	0.57	0.57	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	13.35	7.16	2.56	1.71	1.17	1.28	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	14.30	2.80	0.56	2.24	1.12	0.56	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	14.18	4.61	1.20	1.54	0.85	0.85	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	12.03	5.83	1.46	1.28	0.00	0.91	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	10.18	4.41	1.59	1.84	0.61	0.49	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	11.15	4.43	1.88	3.09	0.94	0.94	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	12.27	4.72	1.65	0.94	0.47	1.65	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	11.51	3.77	1.19	1.98	0.60	0.99	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	11.22	4.21	0.94	2.81	0.94	0.94	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	9.54	4.77	1.87	1.04	1.04	1.45	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	8.18	3.76	1.33	2.88	0.22	1.55	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	11.28	3.55	1.67	2.30	0.42	1.25	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	13.59	6.73	2.15	2.15	0.94	0.94	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	11.92	4.94	1.36	2.55	0.68	1.36	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	12.72	4.63	1.54	3.28	1.16	0.77	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	7.57	4.47	1.72	1.20	0.69	1.55	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	14.40	3.98	1.10	1.37	1.78	1.65	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	10.01	4.93	1.15	2.13	0.66	0.82	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	12.61	4.26	1.87	2.56	1.02	2.22	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	11.39	5.62	0.89	2.52	1.18	1.18	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	15.19	3.73	2.13	2.93	0.53	0.80	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	14.93	5.53	2.49	1.52	0.69	2.07	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	13.33	4.29	1.43	1.90	0.24	1.67	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	15.52	4.64	1.21	2.42	0.60	1.81	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	8.66	3.58	1.13	1.51	0.85	1.32	0.00	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	8.73	6.29	2.45	0.70	0.00	2.10	0.00	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	9.07	1.51	1.21	1.81	0.91	2.42	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	10.40	4.16	1.84	1.47	0.49	0.61	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	26.35	6.11	2.77	4.51	1.16	2.47	0.15	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	7.30	5.48	0.00	5.48	0.61	1.22	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	9.64	4.52	2.11	0.60	0.30	0.90	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	8.60	2.94	1.13	2.94	0.68	1.81	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	11.08	5.99	1.50	0.60	1.20	1.80	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	12.75	2.72	2.36	1.89	0.12	0.94	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	7.90	2.99	1.49	2.99	0.43	0.85	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	15.63	3.00	0.60	3.61	1.20	0.60	0.00	0.60
Schwann Cells, donor1	11498-119F4	8.28	3.95	2.44	1.69	0.19	0.19	0.00	0.19
Schwann Cells, donor2	11578-120F3	20.41	10.21	6.80	0.00	3.40	0.00	3.40	0.00
Schwann Cells, donor3	11659-122F3	22.35	6.79	5.26	0.66	1.97	0.66	0.66	0.88
Sebocyte, donor1	11220-116B5	13.69	7.67	1.64	3.29	2.19	1.10	0.00	0.00
Sebocyte, donor2	11301-117B5	4.14	5.06	0.92	2.76	2.30	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	5.15	3.50	0.82	0.62	1.03	0.21	0.21	0.00
Sertoli Cells, donor1	11255-116F4	64.61	33.13	13.25	3.31	13.25	4.97	1.66	0.00
Sertoli Cells, donor2	11333-117F1	33.89	11.30	2.82	5.65	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	19.18	9.50	2.64	2.38	1.23	0.79	0.18	0.00
Skeletal Muscle Cells, donor2	11358-117H8	5.06	2.17	0.72	0.72	0.72	0.72	1.45	0.00
Skeletal Muscle Cells, donor3	11430-118G8	10.03	8.36	1.67	1.67	2.51	1.67	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	23.72	11.78	3.46	2.98	2.20	0.47	0.00	0.63
Skeletal Muscle Cells, donor5	11455-119A6	16.80	8.18	3.86	1.04	1.19	1.04	0.45	0.74
Skeletal Muscle Cells, donor6	11459-119B1	38.17	21.55	6.46	4.31	4.00	2.46	0.15	0.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	20.41	8.57	3.40	2.27	2.27	1.64	0.13	1.01
Skeletal Muscle Satellite Cells, donor2	11321-117D7	19.12	7.13	3.00	2.14	1.71	1.71	0.29	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	33.43	17.26	4.96	3.37	2.98	1.79	0.30	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	12.55	4.55	2.19	1.43	0.93	0.93	0.25	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	10.13	7.96	1.45	1.45	1.45	0.00	0.00	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	9.08	5.78	0.96	0.83	0.55	0.41	0.28	0.28
Skin - palm, donor1	10286-104F7	5.37	2.69	5.37	0.00	2.69	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	13.98	7.35	2.59	1.73	1.44	0.29	0.29	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	69.52	42.53	12.27	8.18	0.82	0.82	1.64	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	12.46	5.19	3.38	1.82	1.95	0.78	0.39	0.52
Small Airway Epithelial Cells, donor1	11256-116F5	25.30	8.76	4.59	3.20	1.67	1.53	0.70	0.97
Small Airway Epithelial Cells, donor2	11334-117F2	38.26	16.88	7.60	3.38	2.25	1.69	0.70	0.70
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	75.06	37.00	18.18	8.25	4.02	2.54	1.90	2.33
Small Airway Epithelial Cells, donor3	11406-118E2	21.81	13.49	2.40	4.95	4.42	1.72	0.30	0.37
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	19.13	21.60	2.47	3.09	2.47	1.85	0.62	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	29.13	28.01	7.11	2.00	0.89	1.33	0.22	1.11
Smooth Muscle Cells - Aortic, donor0	11210-116A4	31.74	12.93	8.23	2.94	1.76	0.00	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	22.54	3.54	5.08	1.55	0.88	0.22	0.88	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	15.75	7.48	3.94	0.79	2.36	0.79	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	21.63	13.91	3.86	2.32	4.64	1.55	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	13.01	3.00	2.00	2.00	1.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	13.97	6.52	3.59	1.73	1.46	0.13	0.40	0.53
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	19.73	10.86	4.88	2.22	2.88	1.77	0.22	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	26.89	22.02	6.53	3.46	2.82	1.28	0.90	0.64
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	14.65	3.91	7.16	0.65	0.98	0.98	0.33	0.98
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	40.16	16.24	10.63	1.18	4.13	2.07	1.18	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	28.76	15.94	5.55	2.85	2.70	1.00	0.85	1.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	2.93	2.11	0.33	0.49	0.00	0.98	0.16	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	16.44	6.09	3.04	2.13	1.52	0.30	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	24.75	12.38	3.28	2.78	1.52	0.51	0.76	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	0.00	6.12	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	10.97	5.72	4.29	1.43	0.48	0.48	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	32.30	12.68	4.42	3.24	2.21	0.44	0.15	1.03
Smooth Muscle Cells - Colonic, donor2	11320-117D6	25.40	10.76	4.95	2.80	1.51	0.43	0.22	0.86
Smooth Muscle Cells - Colonic, donor3	11396-118D1	28.97	14.17	4.30	2.41	2.10	0.73	0.52	0.63
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	16.09	8.51	6.81	2.32	1.70	0.93	0.62	0.62
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	14.01	9.70	2.16	3.23	1.08	0.00	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	23.61	17.33	5.08	0.90	1.49	0.60	0.60	1.79
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	4.78	1.02	1.02	0.68	0.34	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	21.99	8.17	3.53	1.57	2.12	0.55	0.39	0.47
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	24.36	16.00	3.32	4.93	5.54	1.61	0.50	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	20.93	16.38	4.10	2.73	2.73	0.91	0.46	1.14
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	10.26	8.45	4.83	0.60	0.00	0.60	0.00	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	47.42	24.11	8.74	2.38	4.77	2.91	0.00	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	43.14	22.90	8.39	2.93	2.80	0.40	0.53	0.80
Smooth Muscle Cells - Prostate, donor2	11335-117F3	24.42	16.40	3.01	2.25	3.01	0.63	0.25	0.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	11.16	6.34	1.27	1.01	0.76	0.25	0.25	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	22.47	9.35	6.78	3.17	1.66	1.21	1.36	0.75
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	8.25	4.50	2.25	1.50	2.25	0.75	1.50	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	80.12	6.46	7.75	2.58	2.58	0.00	5.17	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	21.39	10.70	4.65	3.26	1.86	2.33	0.47	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	9.59	5.05	5.05	0.50	2.02	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	19.74	8.78	3.45	0.94	0.31	0.00	0.31	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	1.47	2.06	0.29	0.00	0.00	0.29	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	26.49	10.33	7.16	3.08	2.92	1.83	0.33	0.42
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	15.42	5.14	1.87	0.93	1.40	1.40	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	14.97	6.91	6.62	1.44	1.58	0.43	0.43	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	15.04	6.63	2.80	1.02	0.76	0.00	1.53	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	12.97	6.96	2.63	0.75	1.32	0.94	0.56	0.56
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	55.48	26.13	13.42	4.61	4.33	1.96	0.70	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	66.53	33.35	14.33	4.27	5.19	0.92	1.01	1.09
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	6.67	2.86	0.48	0.48	1.43	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	16.64	8.32	4.65	0.49	3.43	1.47	0.73	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	81.75	31.60	21.65	5.52	3.98	2.21	3.76	2.87
Smooth Muscle Cells - Uterine, donor3	11466-119B8	33.06	12.00	5.85	1.46	1.76	0.59	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	16.52	10.50	1.75	1.36	1.17	0.97	0.58	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	16.66	14.28	2.38	1.85	2.12	0.00	1.32	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	17.48	7.44	1.49	0.74	1.49	0.37	0.00	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	39.89	16.53	5.75	3.59	2.87	0.72	2.16	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	41.45	25.27	4.83	3.69	2.84	1.14	1.99	1.14
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	15.36	7.09	1.18	3.94	0.39	1.18	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	22.86	16.25	3.56	2.29	2.03	1.78	0.00	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	23.96	13.98	2.40	2.00	3.59	0.80	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	14.21	8.36	1.25	0.84	0.42	1.25	0.00	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	9.17	6.42	1.38	1.83	1.38	0.46	0.00	0.00
Synoviocyte, donor1	11291-117A4	35.52	12.62	2.36	4.54	1.85	1.85	0.17	0.00
Synoviocyte, donor2	11368-117I9	14.58	5.53	2.35	1.34	1.01	0.17	0.34	0.17
Synoviocyte, donor3	11440-118H9	5.81	2.90	1.34	2.23	1.34	0.22	0.00	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	5.72	1.43	1.07	0.36	0.36	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	3.96	5.95	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	4.86	1.39	1.16	0.23	0.69	0.46	0.00	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	5.30	3.51	0.93	1.51	0.93	0.72	0.00	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	4.64	2.32	0.77	0.77	0.39	0.39	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	3.44	2.29	0.57	0.00	0.57	0.57	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	34.57	23.87	5.29	4.43	3.81	0.86	0.37	0.62
Urethra, donor2	10319-105A4	8.99	5.40	0.00	1.80	0.00	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	1.33	3.19	0.27	0.27	0.27	0.80	0.00	0.00
Urothelial Cells, donor2	11600-120H7	4.81	1.20	1.20	0.80	0.40	0.00	0.40	0.00
Urothelial Cells, donor3	11681-122H7	1.15	0.69	1.15	0.69	0.23	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	26.08	10.25	3.12	2.45	2.67	1.56	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	0.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	9.13	3.45	1.36	0.86	1.11	1.11	0.12	0.25
Wilms' tumor cell line:HFWT	10597-108E3	7.92	2.64	0.00	2.64	1.76	1.76	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	8.66	9.50	1.68	3.35	2.79	3.07	0.00	0.00
achilles tendon, donor2	10292-104G4	10.33	4.13	0.00	2.07	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	0.00	0.00	0.00	0.25	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	1.16	0.93	1.86	0.93	0.00	0.23	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	0.36	0.00	0.12	0.12	0.24	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	0.82	0.27	1.63	0.00	0.27	0.27	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	0.00	0.00	0.28	0.00	0.00	0.00	0.28	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	0.00	0.42	0.42	0.00	0.00	0.21	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	0.00	0.00	0.27	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	0.00	0.88	0.88	0.00	0.44	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	7.80	0.00	0.00	3.90	0.00	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	0.46	0.23	0.70	0.00	0.00	0.00	0.23	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	0.00	0.00	0.00	0.26	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	0.93	0.93	1.86	0.46	0.00	1.39	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	1.53	0.92	0.61	0.61	0.61	0.92	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	3.41	0.85	0.43	1.28	0.43	0.85	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	3.03	1.82	0.30	2.12	0.91	1.82	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	4.81	0.96	0.72	2.41	0.72	1.20	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	0.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	0.00	1.86	0.00	1.86	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	0.38	0.00	0.75	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	0.00	0.44	0.87	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	2.35	2.59	0.00	2.12	1.18	0.24	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	2.95	2.33	2.64	0.78	0.47	0.16	0.00	0.47
adipose, donor1	10184-103D4	25.80	12.31	0.00	3.52	1.76	2.35	0.00	0.00
adipose, donor2	10185-103D5	7.30	5.68	0.81	2.03	3.24	0.81	0.41	0.00
adipose, donor3	10186-103D6	14.16	9.53	1.36	1.91	2.72	1.09	0.00	0.00
adipose, donor4	10187-103D7	37.27	9.53	0.00	2.60	2.60	1.73	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	3.00	2.05	0.00	3.95	3.31	2.37	0.16	0.00
adrenal gland, adult, pool1	10081-102A9	3.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	31.09	8.58	3.57	5.36	3.22	1.07	0.00	0.36
amniotic membrane cells, donor1	12235-129G3	7.42	6.26	1.62	1.85	4.87	1.39	0.23	0.23
amniotic membrane cells, donor2	12236-129G4	10.14	6.76	0.68	2.37	4.40	1.35	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	2.06	3.24	0.00	1.77	1.77	1.18	0.00	0.00
amygdala - adult, donor10196	10167-103B5	1.19	3.56	0.00	0.00	0.00	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	4.66	2.64	0.61	0.61	0.00	0.00	0.61	0.00
amygdala, newborn, donor10223	10360-105E9	3.87	3.87	0.65	1.61	0.97	0.65	0.97	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	67.10	21.39	16.68	4.58	5.86	2.55	1.66	1.40
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	1.67	4.68	0.00	2.34	0.33	0.67	0.00	0.00
aorta, adult, pool1	10052-101G7	23.54	12.36	5.10	1.77	1.37	0.98	0.59	0.39
appendix, adult	10189-103D9	8.93	4.27	2.33	1.55	0.78	1.16	1.94	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	7.57	4.47	1.03	2.06	0.34	1.38	0.00	0.00
artery, adult	10190-103E1	1.36	2.72	4.08	1.36	0.00	1.36	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	60.55	28.39	6.37	8.55	6.95	3.04	0.43	0.72
b cell line:RPMI1788	10427-106D4	3.87	2.38	1.04	1.04	1.04	1.04	0.00	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	46.06	24.14	6.10	2.22	4.44	1.39	1.11	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	16.47	6.15	2.48	4.17	3.47	2.48	0.20	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	3.51	3.51	0.17	3.01	1.34	1.84	0.00	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	26.62	14.56	3.91	3.69	1.41	1.41	0.65	0.00
blood, adult, pool1	10053-101G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	23.12	11.99	6.85	2.57	2.57	1.71	1.71	0.00
bone marrow, adult	10192-103E3	10.12	4.72	2.70	0.67	0.00	0.00	1.35	0.67
brain, adult, donor1	10084-102B3	1.03	1.03	0.00	0.00	1.03	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	2.56	1.56	0.78	0.11	0.33	0.22	0.11	0.33
brain, fetal, pool1	10085-102B4	5.34	2.67	0.00	0.00	2.67	0.00	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	2.64	2.31	0.33	0.66	0.00	0.66	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	4.24	3.99	0.37	1.62	1.00	0.50	0.00	0.00
breast, adult, donor1	10080-102A8	1.89	1.89	1.26	0.00	0.00	0.63	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	12.58	8.38	0.89	8.00	5.08	4.19	0.13	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	9.90	5.26	1.86	2.78	0.93	0.93	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	6.91	3.22	0.46	5.06	1.61	1.84	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	10.41	4.60	0.97	0.24	0.97	1.45	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	1.41	6.58	0.00	1.88	0.94	0.47	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	15.53	7.44	0.66	2.41	2.52	1.20	0.11	0.44
carcinoid cell line:SK-PN-DW	10719-109I8	0.95	2.85	0.00	2.54	0.95	0.95	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	11.98	6.12	0.53	2.93	1.06	1.33	0.00	0.00
caudate nucleus - adult, donor10196	10177-103C6	3.45	2.30	1.15	0.00	0.00	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	4.02	2.18	0.17	0.17	0.33	0.00	0.00	0.00
caudate nucleus, adult, donor10258	10379-105H1	3.06	1.53	0.00	0.76	0.00	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	9.52	4.03	0.37	1.10	0.37	1.10	0.37	0.00
cerebellum - adult, donor10196	10173-103C2	5.83	2.91	0.00	2.91	14.57	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	8.54	4.91	1.71	2.14	0.64	1.49	0.00	0.64
cerebellum, adult, pool1	10083-102B2	1.38	3.10	0.69	1.03	0.34	0.00	0.34	0.34
cerebellum, newborn, donor10223	10357-105E6	8.30	2.49	0.83	2.49	0.00	0.83	0.00	0.83
cerebral meninges, adult	10188-103D8	3.78	3.03	1.01	0.76	0.76	0.25	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	5.85	6.58	0.73	0.73	0.00	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	9.78	18.40	2.01	6.18	2.73	1.58	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	2.49	1.66	0.33	1.16	0.83	0.66	0.00	0.00
cervix, adult, pool1	10013-101C4	32.23	14.38	5.25	3.88	3.15	1.47	0.52	0.52
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	68.42	39.29	12.12	5.57	3.76	1.95	0.42	0.84
chondrosarcoma cell line:SW 1353	10700-109G7	30.04	31.35	0.00	5.23	2.61	2.61	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	28.46	15.91	0.99	5.10	4.23	1.49	0.00	0.12
choriocarcinoma cell line:SCH	10785-110H2	5.17	7.39	0.25	1.11	0.49	0.25	0.00	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	9.96	7.35	0.00	2.61	4.27	3.08	0.00	0.24
chorionic membrane cells, donor1	12238-129G6	20.80	13.11	4.84	2.28	0.85	0.28	0.85	0.57
chorionic membrane cells, donor2	12239-129G7	61.85	32.61	8.95	3.78	3.18	1.09	0.50	0.40
chorionic membrane cells, donor3	12240-129G8	24.73	12.64	4.95	2.75	2.20	1.10	1.65	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	1.54	0.77	2.31	0.58	0.96	0.00	0.19	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	0.84	0.21	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	7.96	3.34	1.80	1.28	0.26	1.54	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	8.95	5.56	0.48	2.66	1.21	1.21	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	9.77	5.50	0.81	4.07	1.63	1.83	0.00	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	4.71	5.59	0.29	4.12	1.47	2.36	0.00	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	0.00	0.26	0.00	0.00	0.00	0.00	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	51.66	29.49	4.80	13.49	6.63	2.51	0.23	0.91
clear cell carcinoma cell line:TEN	10636-108I6	55.70	17.35	6.94	6.07	5.90	1.56	0.52	0.17
colon carcinoma cell line:CACO-2	10513-107D9	19.22	10.80	1.46	2.01	1.28	0.92	0.00	0.00
colon carcinoma cell line:COLO-320	10420-106C6	64.99	74.50	1.52	25.09	17.86	20.14	0.76	0.38
colon, adult, donor1	10082-102B1	4.76	2.38	0.00	1.19	0.00	0.00	2.38	0.00
colon, adult, pool1	10014-101C5	5.64	4.23	1.76	1.76	0.12	0.24	0.59	0.47
colon, fetal, donor1	10070-101I7	4.33	3.09	0.62	1.24	0.62	0.00	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	4.25	0.42	0.85	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	5.58	1.21	1.21	0.60	0.15	0.00	0.00	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	6.91	0.56	1.83	1.27	0.00	0.14	0.00	0.00
corpus callosum, adult, pool1	10042-101F6	7.96	6.63	1.88	1.44	0.77	0.66	0.00	0.44
cruciate ligament, donor2	10295-104G7	14.59	4.05	2.43	0.00	0.00	0.81	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	8.03	5.62	2.41	1.61	0.00	1.61	1.61	0.80
diencephalon, adult	10193-103E4	6.96	3.84	0.48	0.00	0.24	0.24	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	4.62	3.33	1.03	3.33	0.77	3.85	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	2.89	2.41	0.00	0.48	0.72	0.48	0.00	0.00
ductus deferens, adult	10196-103E7	22.43	8.97	2.99	1.50	1.00	1.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	4.32	4.32	4.32	0.00	0.00	0.00	1.44	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	9.56	4.41	4.41	0.74	0.00	1.47	2.21	0.74
dura mater, adult, donor1	10041-101F5	12.22	4.79	7.19	1.73	0.58	0.33	0.58	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	17.10	5.33	0.89	2.22	0.89	0.67	0.00	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	20.63	6.02	2.44	2.87	1.86	1.72	0.00	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	16.65	4.93	1.85	6.78	3.08	3.70	0.00	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	15.44	9.99	3.94	9.08	4.84	3.94	0.00	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	14.51	5.87	0.62	3.09	2.78	1.54	0.00	0.31
embryonic pancreas cell line:2C6	10603-108E9	21.02	5.25	1.31	6.57	1.31	3.94	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	50.61	16.09	3.02	5.36	4.02	2.35	0.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	32.80	14.86	4.35	5.26	5.07	3.99	0.00	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	23.00	6.43	2.41	2.41	2.09	0.64	0.32	0.32
epidermoid carcinoma cell line:A431	10426-106D3	2.78	3.00	0.11	1.33	0.67	0.67	0.00	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	12.43	16.39	1.76	8.14	4.29	2.97	0.00	0.00
epididymis, adult	10197-103E8	9.42	5.02	2.09	2.30	1.26	0.63	0.63	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	67.42	34.06	9.05	6.21	5.50	3.19	1.06	0.71
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	30.67	12.58	3.93	3.54	1.57	2.75	0.00	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	2.62	1.44	0.39	1.83	0.13	0.26	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	1.57	1.28	0.10	1.08	0.30	0.20	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	1.68	1.57	0.22	1.79	0.90	0.56	0.00	0.00
esophagus, adult, pool1	10015-101C6	6.58	6.26	2.44	1.91	1.70	0.64	0.42	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	0.38	0.38	0.00	0.13	0.13	0.25	0.00	0.00
eye - muscle inferior rectus, donor1	10272-104E2	2.41	4.83	0.00	4.83	2.41	0.00	4.83	2.41
eye - muscle lateral, donor2	10298-104H1	0.00	2.10	0.00	0.00	0.00	0.00	4.21	0.00
eye - muscle medial, donor2	10299-104H2	11.91	4.46	4.46	1.49	0.00	0.00	1.49	1.49
eye - muscle superior, donor2	10297-104G9	6.88	4.59	0.00	1.15	1.15	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	16.03	5.83	2.91	0.00	0.00	0.00	2.91	0.00
eye, fetal, donor1	10054-101G9	8.39	5.85	1.78	1.02	0.76	0.51	0.25	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	27.44	11.16	7.31	2.56	4.87	1.92	0.77	0.77
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	40.60	16.86	8.31	3.56	4.75	3.32	0.24	0.95
frontal lobe, adult, pool1	10040-101F4	3.28	2.35	0.47	0.38	0.28	0.28	0.28	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	3.30	3.30	0.30	0.90	0.90	0.30	0.00	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	142.18	47.09	25.51	14.81	11.16	4.48	1.83	2.10
gall bladder, adult	10198-103E9	9.42	6.52	1.21	1.45	1.21	1.21	0.48	0.48
gamma delta positive T cells, donor1	11937-126A2	0.00	0.00	0.54	0.00	0.00	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	0.37	0.00	0.37	0.00	0.00	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	6.76	5.07	0.84	1.48	1.27	0.63	0.00	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	29.01	17.99	2.90	7.74	5.61	5.03	0.58	0.39
gastric cancer cell line:AZ521	10549-107H9	12.62	12.30	0.49	9.02	2.30	3.61	0.16	0.00
gastric cancer cell line:GSS	10560-108A2	5.49	10.07	0.00	3.66	3.66	7.32	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	23.53	7.08	2.74	0.69	1.37	0.69	0.00	0.46
giant cell carcinoma cell line:LU65	10487-107B1	5.62	5.28	0.34	2.75	1.15	1.72	0.00	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	40.03	11.06	6.72	3.22	3.50	2.66	0.14	0.70
glassy cell carcinoma cell line:HOKUG	10688-109F4	0.75	1.50	0.50	0.75	0.25	0.50	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	26.60	12.14	4.12	2.85	2.01	2.22	0.21	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	29.77	13.90	4.21	3.23	1.83	1.54	0.28	0.00
glioblastoma cell line:T98G	10485-107A8	14.02	6.62	1.66	2.43	1.43	1.32	0.11	0.00
glioma cell line:GI-1	10413-106B8	34.85	14.35	2.93	3.51	2.34	1.46	0.00	0.29
globus pallidus - adult, donor10196	10175-103C4	3.64	2.19	1.46	0.00	0.73	0.73	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	10.98	9.28	2.20	0.98	0.73	0.73	0.49	0.00
globus pallidus, adult, donor10258	10367-105F7	1.37	2.74	0.00	2.74	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	4.26	1.07	0.00	1.07	0.00	0.53	1.07	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	22.40	14.72	3.84	1.28	1.60	0.64	0.32	0.32
hIPS +CCl2, biol_rep1	14383-156B9	21.58	5.97	3.21	2.30	0.46	2.30	0.00	0.46
hIPS +CCl2, biol_rep2	14384-156C1	19.66	5.94	2.74	3.20	0.46	0.91	0.00	0.46
hIPS +CCl2, biol_rep3	14385-156C2	10.95	6.44	1.29	2.58	1.93	1.29	0.00	0.00
hIPS, biol_rep1	14380-156B6	20.12	10.06	2.87	4.31	0.00	1.44	0.00	0.00
hIPS, biol_rep2	14381-156B7	17.83	7.54	0.69	2.74	0.69	0.69	0.00	0.00
hIPS, biol_rep3	14382-156B8	5.52	5.52	2.21	0.00	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	8.33	3.45	2.01	1.15	0.57	0.86	0.00	0.00
heart - mitral valve, adult	10205-103F7	9.57	4.78	2.39	0.90	0.90	0.90	1.20	0.00
heart - pulmonic valve, adult	10206-103F8	11.24	5.75	2.35	1.31	0.78	0.00	0.52	0.00
heart - tricuspid valve, adult	10207-103F9	15.82	7.49	7.49	5.83	0.83	0.83	1.67	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	0.82	1.22	0.82	0.00	0.20	0.00	0.20	0.41
heart, adult, diseased, donor1	10051-101G6	0.85	0.00	0.00	0.85	0.00	0.00	0.00	0.00
heart, adult, pool1	10016-101C7	2.76	2.07	1.84	0.46	0.23	0.00	0.00	0.00
heart, fetal, pool1	10046-101G1	12.73	7.19	4.21	2.67	1.33	1.03	0.41	0.82
hepatic mesenchymal tumor cell line:LI90	10778-110G4	78.67	45.97	11.72	4.94	8.64	3.39	2.78	1.85
hepatoblastoma cell line:HuH-6	10633-108I3	19.03	10.70	0.00	2.38	0.00	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	10.17	6.08	1.33	1.44	0.88	0.77	0.00	0.11
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	12.38	5.95	0.49	1.82	1.34	0.85	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	11.42	4.95	0.91	2.43	1.52	0.40	0.00	0.00
hepatoma cell line:Li-7	10484-107A7	10.45	4.23	0.33	0.56	0.56	0.33	0.11	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	2.84	1.89	0.00	0.00	0.95	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	6.94	4.29	0.82	0.00	0.00	0.20	0.00	0.00
hippocampus, adult, donor10258	10374-105G5	1.49	1.99	1.00	0.50	0.00	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	3.17	2.82	1.06	1.76	0.00	0.00	0.70	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	29.30	15.87	5.49	6.71	6.10	4.27	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	24.94	10.01	1.96	3.73	4.52	3.14	0.39	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	26.41	8.38	1.27	6.35	1.78	2.54	0.51	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	9.59	3.38	0.00	2.82	1.69	1.69	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	14.98	8.78	0.52	2.32	1.29	0.77	0.00	0.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	11.77	5.31	0.76	2.28	1.14	0.76	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	19.27	9.05	1.46	3.50	2.04	0.88	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	15.73	8.62	1.29	3.02	1.29	1.29	0.00	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	15.85	9.18	0.42	5.00	0.83	1.25	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	19.18	6.87	1.89	3.08	0.95	0.47	0.47	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	20.73	7.88	1.61	4.34	2.09	1.77	0.16	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	17.51	7.41	2.69	2.69	1.35	2.02	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	16.74	5.01	2.03	3.76	3.44	1.88	0.16	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	15.23	2.46	1.97	1.97	1.47	2.46	0.98	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	17.46	5.24	1.75	3.49	1.75	1.75	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	19.47	6.49	0.76	3.25	3.63	1.91	0.00	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	14.39	5.23	0.87	3.49	1.31	0.87	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	10.99	6.50	0.00	3.50	1.50	2.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	8.48	5.46	0.75	1.88	2.07	0.38	0.00	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	7.73	4.09	1.82	1.36	0.45	1.36	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	6.58	4.07	0.63	0.63	1.25	1.57	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	17.15	4.74	2.45	1.80	2.29	2.12	0.33	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	14.52	7.26	1.74	3.19	4.35	1.74	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	13.15	6.88	1.79	1.20	2.39	1.20	0.00	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	17.55	7.76	2.22	3.51	2.77	1.66	0.18	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	19.11	6.56	1.71	3.71	3.42	1.14	0.29	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	25.72	9.80	0.82	5.31	4.08	4.49	0.00	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	10.91	9.15	1.41	3.87	1.41	2.11	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	11.40	6.33	0.32	1.58	1.90	1.27	0.00	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	10.59	7.57	0.61	2.72	0.91	2.72	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	4.14	6.72	1.03	3.62	1.55	1.55	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	8.63	1.33	0.00	1.33	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	7.95	3.85	0.00	2.05	0.51	0.77	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	12.78	6.14	3.07	3.32	2.56	2.30	0.00	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	12.12	6.82	3.03	3.03	2.27	0.76	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	16.13	3.02	2.02	3.36	2.35	3.70	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	18.35	5.80	2.66	2.66	3.62	2.90	0.48	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	13.82	3.57	0.89	4.01	3.57	3.57	0.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	21.95	6.83	2.44	7.32	1.95	1.46	0.00	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	14.36	5.50	0.92	1.83	1.83	0.92	0.00	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	52.05	13.01	3.25	3.25	3.25	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	16.55	6.62	0.99	1.99	0.99	1.99	0.00	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	13.68	7.11	1.09	2.19	0.55	1.64	0.00	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	10.13	3.62	0.36	1.09	1.09	1.81	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	10.68	6.41	1.42	2.49	1.78	2.49	0.00	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	10.74	5.97	2.39	3.58	1.19	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	26.68	12.46	4.20	3.79	4.20	2.17	0.27	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	15.89	6.73	1.08	5.39	2.16	1.35	0.27	0.00
immature langerhans cells, donor1	11904-125F5	0.00	0.48	0.00	0.00	0.00	0.00	0.00	0.00
immature langerhans cells, donor2	11905-125F6	2.38	1.58	0.79	2.38	0.00	0.79	0.00	0.00
insula, adult, pool1	10039-101F3	3.60	1.99	0.66	0.57	0.09	0.19	0.19	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	8.13	6.18	0.65	2.93	3.90	1.63	0.00	0.33
kidney, adult, pool1	10017-101C8	8.71	4.91	1.40	1.20	0.60	0.50	0.20	0.20
kidney, fetal, pool1	10045-101F9	14.43	7.29	4.53	2.05	1.91	0.92	0.50	0.57
large cell lung carcinoma cell line:IA-LM	10509-107D5	29.54	13.07	3.83	6.53	5.68	2.98	0.99	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	2.35	1.24	0.55	0.41	0.41	0.41	0.00	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	5.14	3.49	0.37	2.02	1.28	1.10	0.00	0.00
left atrium, adult, donor1	10079-102A7	2.18	1.63	1.09	0.00	0.00	0.00	0.00	0.54
left ventricle, adult, donor1	10078-102A6	1.52	0.51	0.00	0.00	0.00	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	22.99	14.01	3.59	2.51	1.44	0.72	0.72	0.00
leiomyoma cell line:15242A	10570-108B3	20.11	14.67	3.26	1.63	5.43	1.09	0.54	0.00
leiomyoma cell line:15425	10571-108B4	27.20	12.38	3.89	1.70	2.67	0.49	1.70	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	19.05	6.35	6.35	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	33.46	8.36	6.27	1.05	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	7.20	5.19	1.42	2.13	0.94	0.94	0.00	0.00
liposarcoma cell line:KMLS-1	10782-110G8	19.06	6.25	3.44	1.25	2.19	0.78	0.47	0.62
liposarcoma cell line:SW 872	10726-110A6	38.26	18.64	6.34	4.75	4.63	1.46	0.37	0.12
liver, adult, pool1	10018-101C9	9.08	2.11	0.97	0.81	0.16	0.32	0.00	0.00
liver, fetal, pool1	10086-102B5	4.70	1.88	0.00	0.00	0.00	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	5.25	5.40	0.44	1.75	0.15	0.58	0.00	0.15
locus coeruleus, adult, donor10252	10165-103B3	7.38	4.06	1.66	1.48	0.74	0.37	0.00	0.37
locus coeruleus, adult, donor10258	10375-105G6	4.51	3.67	0.00	0.85	0.00	1.13	0.28	0.28
locus coeruleus, newborn, donor10223	10362-105F2	4.21	1.68	1.26	0.84	0.42	0.42	0.00	0.42
lung adenocarcinoma cell line:A549	10499-107C4	12.18	5.81	0.42	2.77	1.52	0.97	0.00	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	20.68	11.03	4.14	9.65	6.89	5.52	0.00	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	29.92	13.45	0.92	6.33	5.80	4.35	0.13	0.26
lung, adult, pool1	10019-101D1	14.29	7.21	5.08	1.06	1.18	0.95	0.95	0.47
lung, fetal, donor1	10068-101I5	22.26	16.84	14.56	5.42	1.43	1.43	1.43	2.28
lung, right lower lobe, adult, donor1	10075-102A3	10.08	6.87	1.83	0.46	0.00	0.00	1.37	0.92
lymph node, adult, donor1	10077-102A5	0.95	2.84	3.79	0.95	0.00	0.00	1.42	0.47
lymphangiectasia cell line:DS-1	10727-110A7	0.00	0.22	0.00	0.00	0.00	0.00	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	6.80	4.25	0.85	1.70	0.85	2.55	0.00	0.00
mature adipocyte, donor1	12231-129F8	0.89	0.44	0.00	0.89	0.00	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	0.62	0.83	0.83	0.21	0.21	0.00	0.21	0.21
mature adipocyte, donor3	12233-129G1	0.24	0.24	0.71	0.00	0.24	0.00	0.00	0.00
mature adipocyte, donor4	12234-129G2	0.79	0.26	0.00	0.53	0.00	0.00	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	22.63	14.30	1.67	13.58	7.62	9.53	0.24	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	2.26	3.38	0.00	0.00	0.00	1.13	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	4.78	1.66	1.29	0.55	0.18	0.18	0.00	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	1.27	1.59	0.95	0.00	0.00	0.00	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	7.25	5.12	0.85	1.28	0.85	0.00	0.00	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	1.86	1.18	0.34	0.68	0.17	0.00	0.00	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	4.46	2.97	1.06	0.21	0.21	0.21	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	0.00	1.93	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	8.26	5.38	0.36	1.08	0.72	0.36	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	9.73	4.54	0.00	0.65	1.30	0.65	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	11.61	5.11	1.08	2.01	1.08	0.31	0.31	0.15
medulla oblongata, adult, pool1	10038-101F2	5.96	4.57	1.22	1.22	0.41	0.49	0.16	0.16
medulla oblongata, newborn, donor10223	10361-105F1	3.82	1.74	0.69	2.08	0.69	0.35	0.35	0.00
medulloblastoma cell line:D283 Med	10838-111E1	21.70	11.51	1.55	3.32	3.99	3.99	0.00	0.00
medulloblastoma cell line:ONS-76	10759-110E3	16.26	9.54	2.32	3.67	3.30	2.20	0.00	0.37
melanoma cell line:COLO 679	10514-107E1	16.67	9.34	2.01	2.87	1.29	0.43	0.00	0.43
melanoma cell line:G-361	10465-106H6	7.87	8.42	0.27	3.80	0.81	0.81	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	30.93	12.48	6.51	3.98	2.35	1.09	1.81	1.27
merkel cell carcinoma cell line:MKL-1	10843-111E6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	5.18	5.70	1.56	1.81	1.04	0.52	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	40.97	29.31	6.75	3.07	2.30	0.61	0.46	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	38.72	28.54	8.00	2.54	1.45	0.36	0.91	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	21.53	18.22	4.56	1.66	0.83	2.07	0.41	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	15.31	16.86	2.25	1.26	2.53	0.56	0.28	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	15.98	13.86	2.50	1.16	1.93	0.77	0.39	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	21.52	5.55	1.39	0.69	2.78	0.69	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	14.76	14.76	2.92	1.89	1.89	1.89	0.17	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	21.51	19.55	3.34	2.42	1.27	0.81	0.23	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	21.75	16.71	5.04	2.25	1.33	0.53	0.27	0.93
mesenchymal precursor cell - cardiac, donor4	11755-123G9	19.72	14.58	5.40	1.62	1.08	0.81	0.41	0.54
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	54.63	40.40	12.52	3.56	3.13	0.71	1.56	1.56
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	24.70	14.49	5.27	1.65	1.65	0.33	1.65	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	59.50	38.19	15.77	3.60	2.35	1.25	1.11	1.52
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	28.97	13.61	6.28	1.05	3.49	2.44	0.00	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	40.63	28.17	7.35	3.27	3.67	1.22	1.22	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	43.49	17.25	7.55	2.88	4.31	0.72	0.72	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	62.17	49.04	11.07	3.00	4.24	0.83	1.03	0.52
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	44.46	25.54	6.38	1.37	1.37	1.82	1.60	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	53.28	39.86	15.10	5.03	4.62	2.94	1.68	1.68
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	44.68	33.92	9.12	2.09	2.39	0.90	0.75	1.05
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	41.40	24.86	10.33	2.71	1.31	0.70	0.79	1.14
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	38.66	23.19	7.36	4.05	2.95	0.74	0.37	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	69.25	28.04	10.87	4.86	4.58	2.29	1.14	1.43
mesenchymal stem cell line:Hu5/E18	10568-108B1	16.84	9.68	2.95	3.37	0.84	1.68	0.00	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	8.22	6.39	0.91	0.91	0.46	0.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	8.95	6.14	1.79	0.77	0.51	0.77	0.26	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	12.83	6.81	1.83	1.57	1.05	0.52	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	10.47	7.39	1.23	2.77	1.23	0.62	0.00	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	10.59	6.12	1.41	0.47	0.71	0.94	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	10.83	7.11	2.03	1.02	0.68	1.02	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	9.04	3.93	0.79	0.39	1.96	1.57	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	8.80	4.17	0.93	0.93	1.85	1.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	12.98	8.65	1.15	2.02	2.02	0.58	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	10.71	5.80	1.78	1.78	0.89	1.12	0.00	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	11.30	6.25	1.44	1.92	0.00	0.24	0.00	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	13.20	8.80	2.20	0.73	2.20	0.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	8.73	3.02	0.67	2.01	1.01	1.01	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	6.96	5.73	1.23	0.82	0.00	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	11.60	6.01	0.43	0.43	0.43	1.29	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	0.00	8.20	2.73	2.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	5.16	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	9.74	2.60	0.97	2.60	0.97	0.97	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	14.55	14.55	0.00	0.00	1.45	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	9.06	4.26	1.07	3.20	0.53	0.53	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	12.27	4.09	0.82	2.45	1.64	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	13.22	4.28	0.78	0.78	1.55	0.78	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	10.49	2.10	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	5.96	7.95	0.00	0.00	0.00	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	4.77	0.00	4.77	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	11.27	3.56	0.59	2.96	2.96	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	6.09	8.53	1.22	2.44	0.00	2.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	27.05	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	6.97	5.70	1.27	0.00	0.63	0.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	3.10	2.07	0.34	1.38	0.00	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	2.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	3.99	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	0.00	3.44	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	1.22	2.04	0.41	0.41	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	1.59	2.38	0.00	0.79	0.79	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	1.18	0.59	0.00	0.59	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	1.25	1.87	0.31	0.62	0.31	0.94	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	2.67	4.01	0.00	0.00	1.34	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	0.00	1.18	0.00	2.37	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	2.57	2.57	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	0.69	1.38	0.00	0.69	0.69	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	2.47	0.99	0.00	0.00	0.00	0.49	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	1.27	0.64	0.00	0.64	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	0.40	0.81	0.00	0.81	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	1.27	1.27	0.00	1.27	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	0.00	1.82	0.00	0.61	0.61	0.61	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	0.00	4.52	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	1.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	2.58	1.79	0.20	1.19	0.60	0.20	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	3.24	2.27	0.00	0.00	0.32	0.65	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	2.04	2.04	0.00	2.04	3.06	1.02	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	63.44	30.95	13.93	5.42	3.87	3.09	0.77	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	33.55	25.51	0.94	13.94	11.58	5.20	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	33.13	9.96	4.63	3.01	2.55	0.93	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	29.92	8.55	4.27	0.00	8.55	4.27	4.27	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	23.53	9.97	4.73	2.06	1.64	0.82	0.00	0.21
mesothelioma cell line:Mero-25	10850-111F4	9.08	3.63	2.50	1.59	0.91	0.45	0.23	0.23
mesothelioma cell line:Mero-41	10851-111F5	17.36	5.62	2.69	1.96	0.98	1.96	0.49	0.00
mesothelioma cell line:Mero-48a	10852-111F6	12.40	4.65	1.55	1.77	1.11	1.11	0.44	0.89
mesothelioma cell line:Mero-82	10853-111F7	19.71	11.30	5.26	3.94	2.10	2.63	0.26	0.53
mesothelioma cell line:Mero-83	10854-111F8	17.02	7.49	2.21	1.87	0.85	1.19	0.17	0.68
mesothelioma cell line:Mero-84	10855-111F9	10.87	1.77	1.26	1.26	0.76	1.01	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	37.68	17.60	7.25	5.38	2.07	2.69	0.41	1.45
mesothelioma cell line:NCI-H2052	10847-111F1	41.08	14.41	9.44	4.31	3.81	3.48	0.66	1.49
mesothelioma cell line:NCI-H226	10846-111E9	23.17	8.87	5.97	1.81	0.72	0.18	0.18	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	11.79	4.61	1.88	2.39	1.20	1.88	0.17	0.17
mesothelioma cell line:NCI-H28	10845-111E8	5.09	2.54	0.76	2.29	0.51	1.02	0.00	0.25
mesothelioma cell line:No36	10857-111G2	14.35	4.57	1.30	3.91	3.26	1.96	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	12.73	4.88	3.25	0.81	0.27	0.27	0.00	0.27
migratory langerhans cells, donor1	11901-125F2	0.00	0.19	0.00	0.00	0.00	0.00	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	0.00	0.00	0.00	0.12	0.00	0.00	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	16.32	5.22	0.98	2.61	0.33	0.65	0.00	1.63
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	49.59	32.00	3.18	5.30	7.84	2.33	0.64	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	17.28	13.13	2.76	6.22	5.53	3.46	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	6.65	3.51	0.74	2.22	1.11	0.74	0.00	0.18
myeloma cell line:PCM6	10474-106I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	36.02	20.80	4.06	10.65	3.04	0.00	0.51	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	30.21	10.98	5.10	4.71	3.73	1.37	0.00	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	3.12	4.23	0.22	1.78	2.12	2.12	0.11	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	2.79	3.31	0.37	2.43	2.13	1.69	0.00	0.00
nasal epithelial cells, donor2	12227-129F4	10.49	9.94	1.10	5.52	1.66	1.66	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	93.40	64.42	6.21	17.94	22.55	12.65	0.69	0.69
neuroblastoma cell line:NB-1	10539-107G8	3.55	2.06	0.37	2.25	0.75	0.56	0.00	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	2.74	1.69	0.21	0.84	2.32	0.84	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	1.68	0.37	0.37	0.19	0.37	0.19	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	0.40	0.81	0.20	0.00	0.20	0.40	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	31.67	21.29	5.32	3.46	2.13	1.86	0.27	0.00
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	3.55	1.18	4.40	0.17	0.00	0.34	0.00	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	26.93	13.14	3.21	1.92	1.28	0.64	0.32	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	21.81	10.25	3.42	2.63	1.31	0.53	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	3.66	3.00	0.56	1.12	0.66	0.09	0.00	0.09
occipital cortex - adult, donor10196	10172-103C1	2.06	2.06	0.00	0.00	4.12	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	5.10	4.56	0.54	0.54	0.27	0.27	0.00	0.00
occipital cortex, newborn, donor10223	10355-105E4	4.73	2.91	1.82	0.00	0.36	0.00	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	2.10	1.57	0.79	1.05	0.26	0.26	0.00	0.00
occipital lobe, fetal, donor1	10073-102A1	15.45	13.73	2.15	3.43	2.15	0.00	0.43	0.43
occipital pole, adult, pool1	10036-101E9	1.50	1.02	0.47	0.32	0.24	0.08	0.08	0.16
olfactory region, adult	10195-103E6	1.72	1.72	0.00	0.38	0.76	0.00	0.00	0.00
optic nerve, donor1	10277-104E7	20.01	16.01	6.00	2.00	0.00	2.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	8.54	4.33	1.59	3.53	1.59	1.37	0.00	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	5.08	9.07	0.55	5.91	3.02	2.61	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	11.01	7.45	1.35	2.88	1.19	0.85	0.00	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	21.72	10.16	2.08	4.39	3.70	2.31	0.00	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	30.57	13.52	5.59	4.41	0.88	2.65	0.29	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	82.22	38.31	33.64	16.82	14.95	12.15	5.61	2.80
osteosarcoma cell line:HS-Os-1	10558-107I9	9.75	3.82	1.91	2.97	1.91	0.64	0.00	0.00
ovary, adult, pool1	10020-101D2	10.57	5.77	3.23	1.31	0.70	0.70	0.52	0.44
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	37.95	24.38	5.87	6.05	6.97	3.48	0.37	0.37
pancreas, adult, donor1	10049-101G4	3.76	4.70	2.82	0.00	0.00	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	9.78	6.71	0.56	1.68	2.80	2.80	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	12.27	4.09	4.60	1.19	1.70	0.51	0.00	0.68
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	31.30	16.06	6.79	3.81	4.31	1.16	0.17	0.33
paracentral gyrus, adult, pool1	10035-101E8	4.39	1.65	0.82	1.01	0.09	0.18	0.00	0.00
parietal cortex, adult, donor10258	10373-105G4	8.07	4.40	0.00	0.00	0.73	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	4.70	4.70	0.94	1.88	0.00	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	2.28	2.00	1.14	0.86	0.29	0.00	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	2.91	1.76	1.06	0.53	0.26	0.26	0.26	0.26
parietal lobe, fetal, donor1	10072-101I9	16.49	21.34	4.85	2.91	0.97	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	6.36	2.62	0.75	2.24	1.12	0.37	0.00	0.37
parotid gland, adult	10199-103F1	2.47	3.08	0.62	1.85	0.62	1.85	0.00	0.00
penis, adult	10200-103F2	10.74	5.37	5.37	2.69	0.54	0.00	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	0.19	1.12	0.00	0.56	0.19	0.56	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	13.55	8.01	2.19	1.17	1.46	0.87	0.00	0.15
pineal gland - adult, donor10196	10179-103C8	3.23	0.00	0.00	0.65	0.65	0.65	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	4.15	2.37	0.00	0.59	0.00	0.59	0.00	0.59
pineal gland, adult, donor10258	10377-105G8	1.88	3.14	0.00	0.63	0.00	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	5.06	4.05	2.02	0.00	0.00	1.01	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	5.21	3.13	3.13	1.56	0.52	0.52	0.00	0.52
pituitary gland, adult, donor10258	10378-105G9	1.70	0.00	0.85	0.00	0.00	0.00	0.85	0.00
placenta, adult, pool1	10021-101D3	68.48	44.94	7.53	13.98	9.35	2.26	0.97	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	2.25	0.93	0.40	0.66	1.06	0.13	0.00	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	13.70	4.67	2.96	1.09	0.62	0.31	0.16	0.00
pons, adult, pool1	10033-101E6	6.02	4.82	1.29	1.55	0.60	0.69	0.17	0.34
postcentral gyrus, adult, pool1	10032-101E5	2.53	1.57	0.52	0.44	0.00	0.09	0.00	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	15.44	10.92	0.87	6.55	5.24	4.37	0.00	0.15
prostate cancer cell line:PC-3	10439-106E7	29.40	17.97	5.08	5.45	5.63	2.36	0.36	0.18
prostate, adult, pool1	10022-101D4	10.79	7.44	2.45	3.36	1.18	0.82	0.45	0.54
putamen, adult, donor10196	10176-103C5	2.83	1.65	0.94	0.71	0.24	0.47	0.00	0.00
putamen, adult, donor10252	10152-102I8	5.88	0.00	1.96	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	4.37	5.46	1.09	1.09	2.19	2.19	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	1.69	1.45	0.72	0.24	0.48	0.00	0.24	0.48
putamen, newborn, donor10223	10365-105F5	4.50	2.25	1.50	0.75	0.00	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	25.60	17.75	2.91	9.60	7.86	3.20	0.00	0.29
rectum, fetal, donor1	10067-101I4	16.69	6.95	5.56	6.95	2.78	1.39	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	40.92	9.75	3.82	4.03	1.27	1.91	0.00	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	15.74	5.80	1.24	1.24	3.31	0.41	0.00	0.00
retina, adult, pool1	10030-101E3	14.81	5.57	2.29	1.39	0.89	0.89	0.70	0.10
retinoblastoma cell line:Y79	10475-106I7	11.95	8.83	0.26	3.38	0.78	2.60	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	13.78	5.06	1.41	3.37	2.81	3.66	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	59.11	25.77	3.03	9.85	3.03	2.27	4.55	0.76
salivary acinar cells, donor1	11771-123I7	5.18	4.37	0.32	1.13	1.29	2.27	0.16	0.00
salivary acinar cells, donor2	11772-123I8	1.38	1.65	0.14	0.55	0.83	0.41	0.00	0.14
salivary acinar cells, donor3	11773-123I9	3.97	3.31	0.00	0.66	1.99	1.32	0.00	0.00
salivary gland, adult, pool1	10093-102C3	0.00	6.29	1.14	1.14	0.00	0.57	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	42.49	14.08	9.44	3.88	3.29	2.45	0.59	1.43
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	43.85	18.93	9.17	4.23	5.52	1.65	0.35	1.18
seminal vesicle, adult	10201-103F3	14.28	7.94	1.06	2.12	0.53	0.00	0.00	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	14.33	8.50	2.92	1.94	2.67	0.97	0.00	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	12.33	3.02	2.52	0.75	0.75	0.50	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	18.06	7.02	6.02	2.01	1.00	1.00	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	50.77	19.34	3.36	4.84	3.90	0.67	0.00	0.40
signet ring carcinoma cell line:Kato III	10436-106E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	5.42	4.13	1.68	2.32	0.65	2.58	0.00	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	1.42	1.42	0.71	0.00	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	2.04	0.84	1.80	0.12	0.24	0.12	0.24	0.12
skeletal muscle, fetal, donor1	10066-101I3	7.04	3.02	2.01	1.01	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	6.79	0.00	0.00	0.00	6.79	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	13.26	8.84	3.79	2.52	3.16	0.63	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	60.03	22.35	10.01	5.00	8.00	3.34	0.33	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	13.55	12.92	3.47	2.52	1.58	1.89	0.00	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	2.70	1.54	0.00	2.70	1.16	0.96	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	9.40	5.77	2.14	1.81	1.15	1.98	0.16	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	9.17	5.79	0.48	2.73	2.90	3.22	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	3.27	0.87	0.44	0.44	1.31	0.00	0.00	0.00
small intestine, adult, pool1	10024-101D6	3.58	2.87	1.31	0.84	1.07	0.96	0.36	0.24
small intestine, fetal, donor1	10064-101I1	2.95	1.47	1.23	0.98	0.98	0.74	0.25	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	9.23	5.13	0.51	3.08	1.03	0.51	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	37.99	21.97	3.36	4.65	3.10	1.81	0.78	1.03
somatostatinoma cell line:QGP-1	10781-110G7	3.75	2.68	0.54	1.34	1.07	0.80	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	11.47	9.41	1.15	0.69	1.15	0.46	0.00	0.92
spinal cord, adult, donor10252	10159-103A6	15.38	9.07	1.18	1.18	1.18	0.39	0.79	0.00
spinal cord, adult, donor10258	10369-105F9	6.23	6.23	1.38	0.69	0.00	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	13.42	3.66	1.83	2.44	0.61	0.00	3.05	0.00
spinal cord, newborn, donor10223	10359-105E8	12.40	2.76	1.38	1.84	1.84	0.46	0.00	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	44.51	22.55	8.96	3.14	5.23	1.19	0.75	0.75
spleen, adult, pool1	10025-101D7	11.89	4.96	20.26	0.88	0.99	0.22	7.71	2.31
spleen, fetal, pool1	10044-101F8	23.52	8.98	13.59	2.07	2.46	0.79	4.93	2.38
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	0.31	0.52	0.10	0.72	0.00	0.10	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	5.70	6.08	0.38	4.37	2.09	1.33	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	0.70	0.35	0.35	0.35	0.35	0.00	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	51.21	29.71	4.69	7.43	7.43	3.13	1.17	1.56
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	7.88	6.75	0.90	2.14	2.03	1.58	0.00	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	4.24	5.51	0.00	4.66	1.69	2.12	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	12.69	4.65	2.12	5.08	0.42	1.69	0.00	0.00
stomach, fetal, donor1	10062-101H8	24.56	16.02	6.41	3.20	1.07	2.14	0.00	0.00
submaxillary gland, adult	10202-103F4	5.13	3.42	2.28	2.28	1.14	1.14	1.71	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	12.25	5.82	0.83	1.87	1.04	0.21	0.21	0.00
substantia nigra, adult, donor10258	10371-105G2	1.03	1.55	1.03	0.00	0.00	0.00	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	4.24	5.65	1.41	2.12	0.71	0.71	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	0.69	0.23	0.23	0.69	0.00	0.00	0.00	0.00
temporal lobe, adult, pool1	10031-101E4	2.71	0.76	0.85	0.25	0.08	0.00	0.08	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	13.53	7.12	2.85	2.14	0.71	0.71	0.00	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	11.43	5.27	2.20	2.64	0.88	0.88	0.00	0.44
tenocyte, donor1	11763-123H8	24.44	11.52	5.59	1.40	1.75	1.05	0.00	0.70
tenocyte, donor2	11765-123I1	12.97	6.10	0.76	1.14	0.76	0.00	0.00	0.00
tenocyte, donor3	11768-123I4	12.97	8.15	2.59	2.59	2.59	1.48	0.37	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	10.20	4.59	2.04	2.21	1.02	0.85	0.00	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	9.56	4.16	1.23	1.54	2.77	0.92	0.00	0.00
teratocarcinoma cell line:PA-1	10807-111A6	23.71	5.27	3.41	4.80	5.42	2.63	0.15	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	17.39	7.62	2.03	1.52	2.54	2.41	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	6.43	5.29	1.51	4.54	1.13	3.03	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	24.43	27.37	2.73	3.27	3.49	2.73	0.11	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	15.63	9.45	3.58	2.61	2.61	2.93	0.00	0.33
testis, adult, pool1	10026-101D8	6.55	4.51	1.50	0.97	0.43	0.54	0.32	0.32
testis, adult, pool2	10096-102C6	8.12	3.16	0.90	0.45	0.45	0.90	0.00	0.45
thalamus - adult, donor10196	10168-103B6	9.94	5.52	1.10	1.10	0.00	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	8.28	7.66	0.31	2.19	0.47	0.47	0.16	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	9.24	3.08	0.00	1.54	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	2.47	3.46	0.16	0.33	0.16	0.49	0.00	0.33
thalamus, newborn, donor10223	10366-105F6	5.75	2.88	0.58	1.15	0.00	0.58	0.58	0.00
throat, adult	10209-103G2	3.99	2.75	1.25	0.50	0.50	0.50	0.50	0.00
throat, fetal, donor1	10061-101H7	10.66	5.48	2.13	0.91	1.22	0.30	0.61	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	0.20	0.60	0.00	0.60	0.00	0.20	0.00	0.00
thymus, adult, pool1	10027-101D9	2.39	2.09	0.40	0.30	0.50	0.30	0.10	0.00
thymus, fetal, pool1	10043-101F7	4.36	3.74	1.87	1.45	0.42	0.42	0.21	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	45.07	15.02	7.58	3.86	1.73	0.80	0.40	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	36.60	21.65	8.52	4.47	6.84	2.93	0.70	0.84
thyroid, adult, pool1	10028-101E1	8.30	4.01	2.05	1.68	1.12	0.37	0.93	0.65
thyroid, fetal, donor1	10060-101H6	7.91	4.75	2.90	0.79	0.53	1.05	1.32	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	3.08	15.40	3.08	0.00	0.00	0.00	3.08	0.00
tongue, adult	10203-103F5	2.56	0.47	1.63	0.70	0.47	0.47	0.00	0.23
tongue, fetal, donor1	10059-101H5	6.70	5.91	3.15	1.58	1.18	0.00	0.00	0.79
tonsil, adult, pool1	10047-101G2	3.81	2.70	2.60	1.20	0.70	0.30	0.40	0.40
trachea, adult, pool1	10029-101E2	13.82	8.26	5.56	2.29	3.11	0.74	0.65	0.98
trachea, fetal, donor1	10058-101H4	16.16	10.00	4.23	1.15	1.92	0.77	1.92	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	28.34	21.26	4.96	3.19	3.19	0.35	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	40.43	20.87	8.21	6.69	2.43	2.03	0.41	0.61
transitional-cell carcinoma cell line:JMSU1	10492-107B6	35.10	27.26	2.19	16.30	8.77	5.80	0.00	0.47
tridermal teratoma cell line:HGRT	10694-109G1	102.74	34.25	7.61	7.61	5.71	9.51	1.90	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	4.99	2.29	0.51	0.34	0.17	0.34	0.00	0.08
umbilical cord, fetal, donor1	10057-101H3	12.52	12.52	0.00	4.17	2.09	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	42.49	26.79	11.94	3.58	2.05	1.54	1.71	2.39
uterus, fetal, donor1	10055-101H1	51.19	24.57	6.14	3.07	4.61	2.56	0.51	1.54
vagina, adult	10204-103F6	10.34	9.69	5.17	1.94	1.94	1.94	1.94	0.00
vein, adult	10191-103E2	7.01	2.63	6.14	1.10	1.32	0.00	3.29	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	2.40	1.07	0.80	1.07	1.60	0.53	0.00	0.27